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The prevalence of Autism Spectrum Disorders continues to rise despite barriers of
changes to diagnostic criteria and lack of insurance coverage. Increases in prevalence affect
costs associated with a disorder since cost of health care services are often estimated based on
utilization of services. This can also affect an individual’s ability to access to health care
services. To equitably distribute autism services to individuals an accurate estimation of the true
prevalence of autism is needed.
Access to health care can be influenced by the type of insurance coverage a person holds.
Other factors, such as socio-economic status, ethnicity, location of diagnosis and geographic
residence of the patient may influence the ability of individuals ability to access health care
services. This is potentially also true for autism.
To examine the national prevalence of autism in relation to the type of insurance a person
holds, the region of the country, recent provider visit and SES using a publicly available, data
from the National Health Interview Survey was examined. Statistical methods determined
change in variable proportions over time and a logistic regression model was used to determine
the relationship between the predictor variables (e.g., insurance type, geography, SES, and
provider visit) and a diagnosis of autism.

There were statistically significant differences in the change of the predictor variables
over time, yet the change in percent of proportion was small. The regression model revealed
Medicaid (as compared to Military insurance, private pay and employer-based insurances) was
significantly related to a diagnosis of autism.
Medicaid enrollment appears to provide increased access to a wider variety of autism
services compared to private insurances, which could affect the ability of an individual receiving
an autism diagnosis. However, further exploration of other potential factors were inconclusive,
and future studies should consider more the role of specific provider types as well as site of
diagnosis (educational vs clinical).

Copyright by
Jennifer L.Thompson
2021

ACKNOWLEDGEMENTS

I would like to thank the members of my committee Dr. Fogarty and Dr. Suarez, for their
assistance, time, interest dedication to this project and making it successful. I would also like to
acknowledge and thank my advisor, Dr. Rob Lyerla for his patience, thoughtfulness, and
expertise. I couldn’t have completed this endeavor through the logistics of the pandemic without
their assistance.

I would also like to thank my parents, John, and Marcia Thompson, for supporting,
encouraging, editing, advising, and dealing with the torrent of emotions over the last 5 years.
Without their unending support I could not have accomplished all that I have or have become the
person I am today. And, to my brother Michael, who is always there to fix my technical
difficulties and work through statistical problems with me. Thank you for always helping to
make all my dreams come true. I love you all.
Jennifer L. Thompson

ii

TABLE OF CONTENTS

ACKNOWLEDGEMENTS………………………………………………………..ii
LIST OF TABLES ………………………………………………………………..vi
CHAPTER
I: INTRODUCTION …………………………………………………………

1

Overview…………………………………………………………………... 1
A Brief History of Autism ……………………………………………….. 2
ASD and Health Care ……………………………………………………. 6
Race/Ethnicity……………………………………………………………. 10
Geographic Region ……………………………………………………….. 14
Behavioral Health ………………………………………………………… 17
Socioeconomic Status………………………………………………………18
Statement of the Problem …………………………………………………. 20
Purpose of the Study………………………………………………………. 22
Research Questions………………………………………………………. 24
Significance of the Study……………………………………………………… 25
II: LITERATURE REVIEW………………………………………………........ 27
The Relationship between Autism and Insurance ………………………… 27
Autism and the DSM……………………………………………………….. 33
iii

Table of Contents - Continued
CHAPTER
The Statistical Problems with the DSM…………………………………… 37
Differential Diagnosis in Early Years…………………………………….

40

Shifts in Provider Perception ……………………………………………

41

Increases in Awareness in Education……………………………………… 42
Culture……………………………………………………………………... 43
Socioeconomic Status and Health Care ………………………………….

45

Theoretical Framework……………………………………………………. 49
Summary …………………………………………………………………… 50
III: METHODS………………………………………………………………… 53
Research Questions/ Hypotheses………………………………………….. 53
National Health Survey Sample …………………………………………… 54
Instrumentation …………………………………………………………….. 54
Operation of Variables …………………………………………………….. 55
Analysis…………………………………………………………………….. 57
IV: RESULTS…………………………………………………………………. 59
V: DISCUSSION………………………………………………………………. 63

iv

Table of Contents - Continued

REFERENCES……………………………………………………………………. 69
APPENDICES
A: Definition of Terms ………………………………………………………….78
B: Anderson’s Model of Health Care Utilization……………………………… 80

v

LIST OF TABLES
1. Demographic information for variables related to predisposing conditions
of recipients of autism diagnoses using the DSM IV and DSM -5
from the NHIS survey…………………………………………………………... 59
2. Insurance coverage changes over time in those who received
autism diagnoses under the DSM IV and DSM -5 from NHIS data……………. 60
3. Change in theoretically influential variables over time for those who received
a diagnosis of autism under the DSM IV and 5 from NHIS data…………………60
4. Logistic Regression Results of variables associated with diagnosis of autism
under the DSM-IV and DSM-5 from NHIS for the years 2010 and 2018………. 61

vi

CHAPTER I
INTRODUCTION
Overview
“Autism Spectrum Disorder” has become a familiar term due to the continued increase in
the prevalence of autism disorders over the last 20 years (CDC, 2020) in both the medical and
educational realms. As any disorder, an increase in prevalence results in the increase in
utilization of health care providers and services which are associated with the diagnosis.
Specialized services such as the ones typically recommended to treat autism, are often limited in
availability due to a lack of trained or licensed providers (CMS, 2011). A lack of providers is a
problem as specialized autism services are highly sought after due to the recommendations for a
high level of frequency and intensity of services such as behavioral interventions. This is due to
the intertwined relationship of health care with insurance coverage, access, and utilization of
services.
The ability to access autism services has been limited by the factors of ethnicity, socioeconomic status, geography, and insurance coverage. To access diagnostic and therapy services,
an individual requires an autism specific diagnosing provider and insurance coverage for the
treatment of autism (or the ability to pay out-of-pocket). Yet available autism providers and
insurance coverage/ability to pay does not guarantee access to services also requires an ICD-10
(International Classification of Diseases, 10th Edition) diagnosis code of Autism Spectrum
Disorder (F84.0). The lack of available providers and a lack of health care insurance coverage is
significant for children with autism as they are more likely to require multiple, specialized care
due to co-occurring morbidities such as other developmental disorders, mental health/behavioral
components and intellectual impairments (Cheak-Zamora, N. C. et al., 2017; Prokup, J.A. et al.,
1

2018; Kogan, M D. et al., 2009; Boyle, C. A., 2011;) Due to the presence of multiple disorders
access to services is necessary; without which many symptoms would worsen or intensify
(Boyle, C. A., 2011; Zablotsky, B. et al., 2019; Thomas, K., et al., 2012; Yingling, M., et al.,
2018; Douglas, M.D. et al., 2017). Although it is well documented children with autism
experience an increased frequency of co-occurring disorders, some have not and some still do
not, have access to specialized services. The reason for a lack of access to specialized care
maybe due to a relationship between the diagnosis given and the policy holder’s specific
insurance coverage.
People diagnosed with autism often require multiple specialty therapies (e.g.,
behavioral/mental health, ST, OT), 1:1 assistance with activities of daily living (e.g., requiring
home health aide), respite care (e.g., requiring home health aide) and pharmaceutical
intervention. Many of these services are inaccessible without a diagnosis of an autism spectrum
disorder, which for some individuals is difficult to obtain due to geographic area, insurance
coverage, and socio-economic status. As autism resources are both limited in availability and
high in demand, estimating an accurate prevalence of autism diagnoses is important to ensure
treatment availability for the people who need that treatment as inaccurate estimations of
prevalence can reduce access/availability of resources and services. This allocation of monies for
reimbursement of services is connected to the estimated prevalence of a disorder which is bound
to an ICD-10 diagnosis code; therefore, it is vital to understand the factors which are influencing
the diagnosed prevalence.
A Brief History of Autism
Since the introduction of “infantile autism” as a diagnosis in the 1940s, the stigma and
perception of autism disorders has dramatically shifted. Autism was first characterized by Leo
2

Kanner (a child psychiatrist at Johns Hopkins University) after he studied the behaviors of 11
children institutionalized in a psychological ward. The children exhibited limited communication
abilities and impairments in social interaction (Silverman, C. 2011). This study led to Kanner’s
original theory that autism was an emotional disturbance but that a person’s cognition was not
affected (Zeldovich, L., 2018). Within a few years of Kanner’s study, Hans Asperger completed
a similar study with a small group of children with varying levels of autism symptoms. He
described the behaviors and characteristics of the patients like how Kanner had captured his
group, yet Asperger’s group demonstrated higher level verbal and cognition abilities (Johnson,
C. et al., 2007). Asperger suggested these behaviors were a type of “autistic psychopathy” as
they presented differently than Kanner’s study group. These differences in presentation and
interpretation of symptoms eventually lead to Asperger’s syndrome becoming a stand-alone
diagnosis in the mid-1990s (Johnson, C. et al., 2007). The creation of Asperger’s syndrome as a
separate diagnosis would grow into a community of individuals with strong views of how
different Asperger’s was from Kanner’s Autistic Disorder (Cooper, R., 2014 2012)
As a new diagnosis autism did not garner much attention from the medical community.
At the time, autism was viewed as a form of childhood psychosis from cold or absent parental
interaction (Silverman, C., 2011). As such, there were few assessments a practitioner could use
for diagnosing autism; most diagnoses were made based on clinical judgment and often related to
the level of experience of the practitioner (Silverman, C., 2011). The first formal autism
diagnosis criteria were not established until 1956 when autism appeared as a form of childhood
schizophrenia with an occurrence of a detachment from reality (Zeldovich, L., 2018). “Autism”
symptoms were characterized as “extremely aloof behavior, repetitive and circumscribed
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activities and near typical intelligence” (Silverman, C., 2011). It wasn’t until the 1980s the
diagnosis was expanded from schizophrenia and added to the Diagnostic and Statistical Manual
of Mental Disorders, 3rd edition (DSM-III) as a stand-alone diagnosis (Zeldovich, L., 2018). This
was the first time an operationalize definition of autism appeared in the DSM. The DSM-III
defined Autistic Disorder (AD) in broad terms and included pervasive developmental disordersnot otherwise specified (PDD-NOS) as alternative diagnosis for children who didn’t meet the
autism criteria characteristics (Zeldovich, L., 2018; Silverman, C., 2011, Johnson, C. et al, 2007;
Lai, M.C).
As autism gained prevalence in middle 1980’s two significant discoveries were made in
the fields of neurology and social psychology which changed the way autism was perceived
(Silverman, C., 2011). Neurologists found significant differences between the neurological
patterns of individuals with autism compared to those without when reviewing the MRIs of
patients with and without a diagnosis of autism. It was proposed these differences were due to a
lack of development in the cerebellum which could influence the presentation of autistic
behaviors (Silverman, C., 2011). Social psychologists, on the other hand, proposed a new theory
that individuals with autism lacked the ability to engage in “theory of mind” (TOM) or the ability
to infer the metal state of other (Silverman, C., 2011). Unlike typically developing children or
children born with other developmental disabilities such as Down syndrome, it was suggested
children born with autism lacked the ability to relate with the perspective of others (Silverman,
C., 2011). These discoveries led practitioners to arrive at the conclusion autism was both a
biologically based neurodevelopmental disorder and a social-communication disorder
(Silverman, C., 2011). This view of the presentations of autism allowed for the signs and
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symptoms of autism to be grouped into developmental patterns and compared while also
considering the accompanying biomedical deficits to determine a diagnosis (Silverman, C.,
2011).
The difficulty in finding a specific biological explanation for the underlying cause of
autism has added to the difficulty of identifying autism accurately. The lack of a clear etiology
has required practitioners to rely heavily on clinical judgment to accurately recognize the signs
and symptoms of autism while differentially diagnosing autism from similar developmental
disorders (Silverman, C., 2011). Advancements in autism research, increases in prevalence and
increases public awareness contributed to the addition of Asperger’s syndrome (AS), childhood
disintegrative disorder (CDD) and Rett syndrome to 1994’s DSM-IV (Zeldovich, L., 2018;
Johnson, C. et al, 2007). The additional diagnoses of PDD-NOS, AS, Rhett’s and CDD were
meant to help providers accurately capture autism from other similar disorders. Yet the increase
in the number of similar subcategories of disorders created difficulties for providers when
attempting to differentially diagnosis the symptoms of autism from the other PDDs (Johnson C.
et al. 2007).
Through the 2000s the prevalence of autism increased again causing critics of the DSMIV to argue the additional diagnostic criteria was not sensitive to accurately capture the
differences between the presentation of the PDDs (Lai, M.C., et al., 2014). Critics also claimed
the lack specificity was leading to a lack of consistency among clinicians in varying states
creating an overabundance of autism diagnoses (Lai, M.C., et al., 2014). Epidemiologists
believed the rise in prevalence could be due to several factors: the broadening of the diagnostic
criteria from the DSM-III-R to the DSM-IV, a more thorough identification of autism cases
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found through epidemiological research and better detection of the presence of autism due to
increased public/professional awareness (Silverman, C., 2011).
Following deep criticism, the autism criteria underwent another revision in the 2013
update to the DSM-5 (Bennett, M. & Goodall, E., 2016; Foley-Nicpon, M. et al., 2017; Huerta,
M., Bishop, S. L., Duncan, A., Hus, V., & Lord, C., 2012; Kupfer, D, Frist, M., & Regier, D.,
2002). In this version Autistic Disorder (AD) and the subsequent PDD diagnoses were reduced
to an umbrella term of autism spectrum disorders (ASD), thereby removing the previous
diagnostic categories of (PDD), AS and (NOS) previously added in the DSM-IV revision.
Additionally, the general criteria for meeting an autism diagnosis were reduced from triad into a
dyad (Lai, M.C. et al., 2014). Prior to this change, patients needed to meet the criteria of deficits
in the areas of communication/language, repetitive interests and presenting with atypical
language development (Lai, M.C., et al., 2014; Cooper, R., 2014). Under the DSM-5 patients
only need to meet the criteria for difficulties in social communication/interactions and restricted
repetitive behavior/interests/activities as the condition of atypical language development was
removed (Lai, M.C., et al., 2014, Cooper, R., 2014; Silverman, Cl., 2011). These changes were
meant to reflect individual characteristics, patterns of unique strengths and weakness, and to
remove the ambiguity surrounding the differences between AS, PDD, and PDD-NOS thereby
increasing accuracy of diagnosis (Lai, M.C., et al., 2014; Cooper, R., 2014, Silverman, C. 2011).
Autism Disorders and Health Care
Insurances have not traditionally covered or have only partially covered health care
services for autism due to the high cost resulting from higher rates of utilization of specialized
services (Fry-Bowers, E.K., 2015; Caldwell, J., 2010; Parish, S.L., et al., 2015; Chatterji, P., et
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al, 2015). Individuals with autism have also experienced denials of treatment from providers due
to low reimbursement rates and the constraints from insurance companies such as denial of
payment for costly services (Magana, S. et al, 2012; Wang, L., et al., 2013; Saloner, B. and
Barry, C. 2019; CMS, 2011; Havens, L.A., 2015; DHHS, 2014;Kaiser Foundation, 2016). This
same trend can be seen by reviewing the history of Attention Deficit and Hyperactive Disorder
(ADHD). After ADHD gained more notoriety as a diagnoses and people became familiar with
the signs and symptoms the rate continued to increase (Olfsom, M., et al, 2003) Between 1987
and 1997, the rate of ADHD increased from .9/100 to 3.4/100 across all SES levels and all
ethnicities (Olfsom, M. et al., 2003). ADHD saw an increase in prevalence following increases in
insurance coverage of mental health treatments, increased public awareness, and its inclusion
into the IDEA as an educational eligibility for Special Education services (Olfsom, M. et al.,
2003). As with autism spectrum disorders, minorities diagnosed with ADHD had greater
disparities in the type of treatment they received compared to Caucasian people (Olfsom, M. et
al, 2003). The same trends are outlined in the research on the historical and current prevalence of
autism (Silverman, C. 2011, Cooper, R., 2014).
Denial or non-coverage of treatment places children with ASD at risk for poorer health outcomes
and significant disparities in health care (Cheak-Zamora, N. et al., 2017).
Non and/or limited coverage of therapies have created challenges for individuals and
families in gaining access to a variety of necessary health care services such as Applied Behavior
Analysis (ABA) and Speech Therapy (ST). The lack of access to services is potentially harmful
because 30% of children born with autism experience complex, chronic conditions requiring
multiple, specialized interventions (Cheak-Zamora, N.C., et al., 2017; Lello, F.T. et al., 2019)
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The increased number of co-occurring disorders means an individual will have greater health
care needs as compared to children with fewer co-occurring disorders (Lello, F.T. et al., 2019;
Magana, S. et al., 2012; Prokup, J. et al., 2018; Yingling, M., et al., 2018). The level of severity
of a primary disorder (e.g., autism) is directly related to the number and type of co-occurring or
secondary conditions (e.g., language delays, gross motor impairment, etc.). The greater the
severity, the greater the number of additional therapies which will be required to make functional
gains toward communication and behavioral outcomes (Calvo, R. & Hawkins, S.S. 2015; Park,
C. et al., 2014; Ngyen, C.T. et al., 2016). Not only does the presence of multiple disorders
influence the number and type of providers needed; access to treatments is influenced by a
patient’s primary diagnosis/condition, level of cognitive functioning, insurance coverage, annual
income, and region of residence (Cheak-Zamora, N.C. et al., citing Lollar et al., 2012;
Nageswaran et al., 2008 and Strickland et al., 2014). These factors have created hardships for
some families locating providers qualified to treat children with multiple, severe medical
conditions (Prokup, J. et al., 2018 citing Russell and Simon, 2014). Even if families can find a
provider who is willing and qualified to treat severe developmental disorders, children born with
autism are more likely to experience unmet health care needs as compare to children with other
disabilities (Lello, A., 2019; Prokup, J., et al., 2018; Cheak-Zamora, N. et al, 2017, Magana, S. et
al., 2012). And even though children with autism need consistent, specialized care, they are also
four times more likely than other children to experience delays in receiving care and six times
more likely to have problems gaining referrals to specialists (Prokup, J., et al., 2018; Magana, S.
et al., 2015).
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Meeting health outcomes is particularly important in children with autism as they are not
acquiring skills and behaviors at predetermined developmental benchmarks (Caldwell, J., 2010).
The keys to acquiring absent developmental skills are through habilitative (e.g., any service
which helps a person attain or maintain skills) services versus rehabilitative (e.g., the retraining
of prior skills) services. Children with autism are typically recommended to attend a high
frequency of habilitative services such as speech-language pathology (ST), occupational therapy
(OT) and behavioral services. However, these services have not always been covered by
insurance as such therapies have been viewed as “not medically necessary” or these therapies are
expected to be provided by educational services, who by nature do not submit for insurance
reimbursement (Berlin Baller, J et al., 2016; Karpur, A., et al, 2018; Foxhall, K., 2015; Razi, R.
R. 2017). Habilitative therapists are most important during the early toddler and pre-school years
which are crucial years in a child’s development (Cheak-Zamora, N.C. et al., 2017; Lello, A., et
al., 2016; Travers, J. & Krezmien, M., 2018; Adelman, C.R. & Kubiszynm T., 2017; Daniels,
A.M. and Mandell, D.S., 2014). It is during this developmental stage that the frequency and
intensity of habilitative services can work to reduce the need for intensive interventions later in
life. More importantly these services can be the difference between talking or not talking (FryBowers, E. K., 2015; Zamora, N. et al., 2017).
Individuals with autism continuously face difficulties in gaining access to health care. In
addition to requiring highly specialized care, there are often other preexisting factors influencing
the ability to access levels of health care. The most common factors are race/ethnicity, the need
for additional behavioral/health services, geographic location of the patient (part of the country),
and socio-economic status. These four factors have been consistently found to be associated with
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the difficulty in accessing health care, compounded by also having a developmental disability,
such as autism (Rosen-Reynoso, M. et al., 2016; Magana, S. et al., 2012; Calvo, R. and Hawkins,
S., 2015; Kuang, X. et al., 2017; Glassgow, A.E. and Van Voorhees, B., 2017; Christensen, D. et
al., 2016).
Race/Ethnicity
Minorities have faced persistent disparities in the access, utilization, and quality of health
care due to a complexity of factors such as socio-economic status, lack of health insurance and
unequal access to health care (Jones, D., Crump A., and Lloyd J., 2012, Magana, S. et al., 2012;
Calvo, R. & Hawking, S.S. 2015; Fulkerson, N., et al., 2013; Lello, A., et al., 2019; Magana, S et
al., 2012). These disparities are so deeply engrained in the health care system, that even if all
other factors were equal, such as access to care and adequate health insurance coverage, health
care disparities would still exist between ethnic groups across all health outcomes (Langellier, B,
et al, 2016; Son, E. et al., 2017). Minorities have also consistently experienced difficulties in
accessing health care services compared to other families. Minorities are less like to have a
family doctor or insurance and are more likely live in under-served geographic areas as
compared to Caucasians (Adelman, C. & Kubiszyn, T., 2017; Langellier, B, et al, 2016; Rose, R.
et al., 2010, Magana, S. et al., 2012; Jones, D., Crump A., and Lloyd J., 1971). A lack of
providers and access to services increases the chances a child will not receive a well-child visit
with a pediatrician (Daniels, A.M., & Mandell, D.S., 2014; Marcin, J.P. et al., 2016; Langellier,
B.A., et al., 2016). Well-child screenings are vital to the early identification of autism as
consistent check-ups with the same provider yields a greater chance of diagnosing the signs and
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symptoms of autism early (McGrath, K, Bonuck, K. & Mann M., 2020; (Daniels, A.M., &
Mandell, D.S., 2014; Marcin, J.P. et al., 2016; Langellier, B.A., et al., 2016).
Yet simply having health care insurance is not a guarantor of access to health care
services as minorities still must navigate complex health systems to find providers (Langellier,
B.A., et al., 2016; Son, E. Parish, S., & Igdalsky, L., 2017; Magana, S., Parish, S.L. & Son, E.
2015; Dougherty, D. et al., 2013). Due to this complexity many Black and Asian families are less
likely to have a Primary Care Provider and Latino families are less likely to have coordinated
care between providers, less preventative care, and are more likely to experience a delay in care
(Langellier, B., et al., 2016; Calvo, R. & Hawkins, S. S, 2015; Magana S. et al., 2012; Park, C et
al., 2014; Fulkerson, N. et al., 2013).
A lack of a consistent provider or lack of coordination of care between providers can lead
to delays in diagnosis (Langellier, B., et al., 2016; Calvo, R. & Hawkins, S. S, 2015; Magana S.
et al., 2012; Park, C et al., 2014; Fulkerson, N. et al., 2013). As stated above this is particularly
problematic for those diagnosed with autism. Navigation of health care systems becomes more
complex for parents of children born with special health care needs (SHCN) such as autism,
physical and cognitive impairments since they often require specialized services and programs
not only to treat disorders but also to manage the chronic symptoms (Glassgow, A.E., & Van
Voorhees, B., 2017; Rosen-Reynoso, M et al., 2016; Karpur, A., et al., 2018). In the case of
minority children with SHCN, the health care disparities are felt on a deeper level as compared
to minority children without SHCN due to lack of adequate insurance coverage needed to access
highly specialized services (Yu, S. et al., 2015). Minority families have an estimated 2-4 year
wait between the onset of the signs and symptoms and a diagnosis of specialized disorder such as
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autism (Glassgow, A.E. and Van Voorhees, B., 2017; Kuang, X. et al., 2017; Adelman, D. R. &v
Kubiszn T. 2017).
The navigation of health care systems is not the only barrier minorities face as many also
experience limited insurance coverage and/or high policy deducible costs (Shea, L. L., et al.,
2018; Foxhall, K. 2015; Zhang, W. & Baranek, G., 2016; Candon, M.K. et al., 2019). For many
people a lack of coverage or ability to cover the cost services influences where or if they receive
health care. The variation in the lack of coverage increases the chance of inconsistent provider
visits and discoordination of care (Zhang, W. et al., 2017; Daniels, A.M., & Mandell, D.S. 2014).
An interruption and discoordination of services is harmful in that it can result in delays in
diagnosis and referrals to specialty providers and can create an inconsistency in access to
necessary treatments needed to produce functional outcomes such as verbal communication and
a reduction of non-compliant behaviors such as physical aggression, verbal aggression, and
property destruction (Daniels, A & Mandell, D. 2014; Coombes, J. et al., 2018; Boyle, C.A. et
al., 2011; Travers, J., & Krezmien, M., 2018; Adelman, C.R, & Kubiszyn, T., 2017). Immigrant
and/or English Language Learning (ELL) status further increases the odds of experiencing
greater difficulties of being seen by a provider due to language barriers as only 20% of Spanish
speakers have access to care (Calvo, R. and Hawkins, S., 2015; Kuang, X. et al., 2017;
Fulkerson, N. et al., 2013; Rosen-Reynoso M. et al., 2016). The lack of access to care can be
partially attributed to the fact many immigrant families are ineligible for public insurance due to
the illegality of their citizenship and therefore are less likely to have health insurance (Adelman,
C.R, & Kubiszyn, T., 2017; Langellier, B.A, et al., 2016; Rose, R.A. et al., 2010; Yu, S. Lin, S.
& Strickland, B., 2015; Fulkerson, N. et al., 2013; Rosen-Reynoso, M et al., 2016). A second
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problem facing immigrant families is that many are living well below the Federal Poverty Level
(more than any other minority group) and due to immigrant status do not qualify for Medicaid,
yet they cannot afford to purchase private health insurance (Langellier, B. et al., 2016). This
leads to immigrant children being less likely to have well-child visiting results in delays in care
(Langellier, B. et al., 2012; Zhang, W. et al., 2017). All these challenges are compounded when
an immigrant parent has a child born with a SCHN. The added challenges of obtaining highly
specialized services for their children, reading evaluation reports, finding recommended
therapies, and following up with referrals in an unfamiliar language leads some parents to not
seek medical intervention (Yu, S. Lin, S., & Strickland, B., 2015; Rose, R et al., 2010).
When immigrant parents do seek a provider, providers have been found to be dismissive
of cultural practices and beliefs (Langellier, B. et al., 2012, Jones; D., Crump A., and Lloyd, J.,
1971; Rose, R., et al., 2010). Furthermore, providers are less likely to complete a well-child or
autism screening on a child of an immigrant status person (Son, E. et al., 2017; Langellier, B., et
al., 2016; McGrath, K. et al., 2020). This is concerning since 25% of all children in the United
States belonged to an immigrant or ethnic minority family in 2015 (Calvo, R. and Hawkins, S.,
2015). A lack of child well-visit screenings in the immigrant population increases the possibility
of a child not being identified with a developmental disability, such as autism, until a child
reaches school age and is identified through educational modalities (Christensen, D. L, et al.,
2016; Johnson, C.P & Myers, S.M., 2007;). This creates a large gap between the onset of
symptoms and initiation of treatment which directly impacts therapy outcomes (McGrath, K et
al., 2020; Travers, J. & Krezmien, M., 2018; Adelman, C. R. & Kubiszyn T).
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Access to preventive services is important for any child to develop and grow. Without
access or with reduced access children are at higher risk for reduced overall health status,
increased hospitalizations, and increased medical needs (King, C. 2016; Son, E. et al., 2017;
Langellier, B., et al., 2016). Minorities and immigrants face deeper health care disparities in
access as compared to other ethnic groups. These disparities in access to needed services are
exacerbated when the individual is born with SHCN and does not have insurance coverage.
Geographic Region
Ethnicity is not the only factor in the disparities of the health care systems as regional
differences also contribute to a significant portion of an individual’s overall health disparity level
(Xiaoxin, K. et al., 2017p; Fry-Bowers, E.K. 2015; Zablotsky, B. et al., 2019; Christensen, D. et
al., 2012; Coombes, J. et al., 2018). When comparing overall health care access across regions,
children residing in northern states have increased access to health care services as compared to
children residing in southern states (Fulkerson, N. et al., 2013; Coombes, J. et al., 2018). In
addition, children living in Southern states are also more likely to have unmet medical needs and
children diagnosed with ASD living in the south are less likely to be able to see a specialist when
needed as compared to children living in the North (Fulkerson, N. et al., 2013; Coombes, J. et al.,
2018 Zablotsky, B., Maenner, M.J, & Blumberg, S. J., 2019).
One of the reasons suggested for the significant differences between the North and South
specifically is that the South has historically engaged in racial segregation, discrimination, and
conservatism (Kuang, X., 2017). These ideologies and policies have a direct impact on the health
of people in the form of abject poverty and lack of access to health care services. As a result of
these policies, the Southern states have had the highest population of children living in poverty
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(Kuang, X., 2017; Thomas K., Parish, S., Rose, R., and Kilany, M., 2012). These variations
suggests that the regional differences are more likely due to individual child and family
characteristics (Zablotksky, B. et al., 2019; Adelman, C and Kubiszyn, T. 2017; Daniels, A.M. &
Mandell, D. S. 2014). Other regional differences exist between the northern and western states
when ethnicity is a factor. In the northeast was the highest prevalence of autism was among
Caucasian children. Whereas, in the West the highest prevalence was among Spanish speaking
people (Zablotksky, B. et al., 2019; Christensen, D. et al., 2016 and Xiaoxin, K. et al, 2017).
Not only is a macro level of geography influential on health care access, but local and
community level characteristics also heavily influence a person’s physical health and access to
care (Xiaoxin, K. et al., 2017). Children in rural areas have less access to health care services and
providers and have increased odds of unmet medical needs as compared to children in urban
areas (Fulkerson, N., et al., 2013; Zhang, W. et al., 2017). The odds that a child living in a rural
area has a routine visit with a pediatrician at least once a year since birth decreases significantly
when compared to children in urban area (Xiaoxin, K. et al., 2017; Coombes, J. et al., 2018).
Another factor is that rural areas have long struggled to recruit providers as these areas do not
provide the same opportunities for compensation and lifestyle as cities. In addition, many states
require specialty therapies such as Applied Behavioral Analysis (ABA) and Speech Therapy
(ST) to be licensed in that state to provide services; yet some states have not adopted regulations
establishing licensing for those disciplines (CMS, 2011; Havens, L.A., 2015; DHHS, 2014;
Kaiser Foundation, 2016). This limits the number of qualified and/or specialized providers
attracted to an area among an already small pool of available providers able to deliver quality
services for children with multiple disorders (Zhang, W. et al., 2017; Marcin, J., et al., 2016;
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CMS, 2011; Havens, L.A., 2015; DHHS, 2014;Kaiser Foundation, 2016). In 2016, the number of
sub-specialist providers in rural areas was 40/100,000; in urban areas the ratio was 134 /100,00
(Marcin, J., et al., 2016). Without available providers, rural families are forced to travel long
distances to access care. However, many rural families also face transportation difficulties
(Marcin, J. et al, 2016).
The lack of available providers can create a serious problem for children with behavioral
problems because when behavioral needs are not supported, the behaviors worsen over time
Cheak-Zamora, N.C. et al., 2017; Lello, A., et al., 2016; Travers, J. & Krezmien, M., 2018;
Adelman, C.R. & Kubiszynm T., 2017; Daniels, A.M. and Mandell, D.S., 2014). The worsening
of the behaviors often will result in the need for immediate psychological/medical intervention.
The fastest way for people living in rural communities to gain access to psychiatry and medical
care is through the Emergency Department (ED) (Zhang, W. et al., 2017). The ED has become a
primary source of care for many rural, immigrant and minority families due to a lack of
providers in the area who are qualified to treat their children’s specialized needs. Because of the
lack of providers in rural areas, children with autism are nine times more likely than children
with other DDs to utilize the ED for these reasons (Zhang, W. et al., 2017; Daniels, A.M &
Mandell, D. 2014). Frequent trips to the ED to treat issues which should be managed by a PCP
can equate to the patient seeing too many different providers and lead to a lack of coordination or
incorrect care and for children who much later diagnosis of autism (Daniels, A.M. & Mandell,
D., 2014). However, living in an urban area doesn’t necessarily guarantee a child will have
access to health care. Children in urban areas who lack a supportive neighborhood, or a positive
home or community environment have also been found to have lower rates of preventive medical
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visits (Monz, B. U., Houghton, R., Law, K., & Loss, G.,2019). A supportive environment is
necessary for continued reinforcement of therapeutic goals in different situations. Environments
which are supportive ensures the generalization of skills which are necessary in gaining
independence (Monz, B. U., Houghton, R., Law, K., & Loss, G., 2019).
Behavioral Health
When children experience unmet health care needs, they are at greater risk for developing
chronic health care issues such as developmental delays and behavioral/emotional difficulties
(Glassgow, A. E. & Van Voorhees, B. 2017). Behavioral health services are vital for children on
the autism spectrum as they are more likely than children with other types of DDs to require
these types of interventions. The reason for the increase in need for behavioral health services is
often due to the co-occurring disorders which cause significant delays in communication and
cognitive growth. Lower cognitive and communicative abilities have been associated with higher
incidents of self-injurious behaviors (SIB) (Soke, G.N. et al., 2018). As SIB are unlikely to fade
without intervention, access to behavioral health services is imperative for children to develop
the skills necessary to participate in academic, social and community environments (Boyle, C.A.
et al., 2011; Soke, G.N. et al., 2018). Beyond the presence of SIBs, children with
Autism Spectrum Disorders also exhibit restricted and repetitive behaviors (often bordering on
obsession/compulsion) (e.g., only wanting to eat round foods or only watch “Thomas the Train”)
as well as exhibiting sensory processing challenges (e.g., sensitivities to sound, touch, light) and
food sensitivities (e.g., aversions to textures and temperatures) (DSM-5, 2013). Due to these
difficulties, children with ASDs have been consistently found to have a higher rate of need of
mental and behavioral health services as compared to normally developing children or children
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with other types of disabilities (Glassgow, A. & Van Voorhees, B. 2017; Kogan, M.D. et al.,
2009). Yet, many parents of children with ASD have reported they did not or could not receive
the mental health services they needed (Kogan, M.D. et al., 2009). The need for access to
behavioral health services is imperative for the 10% of children in the United States that have
been diagnosed with a mental illness. Of this group, only 25% of the children who need mental
health services received treatment (Park, C., et al., 2014). To compound matters, children with
autism have a 4% higher prevalence in exhibiting more severe types of behavioral difficulties
such as physical aggression and/or Self Injurious Behaviors (SIB) as compared to typically
developing children. Given that children with ASD are at a higher risk for engaging in selfharm, who also have sensory and compulsive behaviors, they require very specific, skilled
intervention to reduce, fade or replace these behaviors (Soke, G.N., et al., 2018; Glassgow, A. &
Van Voorhees, B. 2017; Kogan, M.D. et al., 2009). As with other developmental difficulties
mental health needs are best addressed earlier in life when it is easier to change or replace a
behavior (Soke, G. N. et al., 2018). If the behavior persists into the school age years, the
behaviors become harder to manage requiring more specialized intervention (Soke, G.N. et al.,
2018). Furthermore, hard to manage behaviors then interfere with academic and social learning
furthering the social and academic gap between children with ASD and their peers (CheakZamora, N.C. et al., 2017; Lello, A., et al., 2016; Travers, J. & Krezmien, M., 2018; Adelman,
C.R. & Kubiszynm T., 2017; Daniels, A.M. and Mandell, D.S., 2014).
Socioeconomic Status
Poverty has long been a risk factor in determining access to health care and/or having
insurance coverage (Fulkerson, N. Haff, D.R. & Chino, M, 2013). Children and families who
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live below the Federal Poverty Levels (FPL) are far more likely to experience unmet health care
needs and not have insurance coverage as many are not eligible for public insurance but do not
earn enough to privately purchase insurance. (Zhang, W. et al., 2017; Zablotsky, B., et al., 2019).
Without insurance, health care becomes a substantial financial burden for many families who
must pay out-of-pocket for supportive therapies, mental health intervention, and medical services
(Berlin Baller, J., et al., 2016; Karpur, A., et al., 2019; Foxhall, K., 2015; Havens, L., 2019;
Candon, M.K., 2019). With the passage of the Affordable Care Act in 2010 access to habilitative
services, mental health services, wellness services and pediatric services was expanded for
children with autism and needed behavioral and therapeutic interventions, people living at or
below the poverty line and people with pre-existing conditions (Caldwell, J., 2010). The
additional Medicaid expansion under the ACA was significant as it provided individuals at 133%
of the FPL to have access to Medicaid insurance (Caldwell, J., 2010) and provided cost sharing
assistance for individuals at 400% of the FPL to purchase insurance provided through the federal
health insurance exchanges (Caldwell, J., 2010; Zablotsky, B., et al., 2019) providing relief for
LSES families and many children with disabilities as a high proportion live below the poverty
level and depend on Medicaid coverage (Caldwell, J., 2010).
As previously mentioned, health care disparities associated with socio-economic level are
compounded for children of minority status as LES areas are more likely to included minorities,
people with public insurance and children with special needs (Rosen-Reynoso, M. et al., 2016;
Fulkerson, N. Haff, D.R. & Chino, M, 2013; Christensen, D. et al., 2016: King, C. 2016). Lower
socio-economic (LSES)areas are also more likely to have limited providers/services which
results in a lower rate of preventative medical care (Kuang, X. et al., 2017), poorer health care
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outcomes and increased utilization of ED services (Prokup J.A. et al., citing Boulet et al, 2009;
Krahn et al., 2006; Scior 2011; Staniland 2009: Wilson and Scior 2015; Park C. et al., 2014).
A lack of access to health care services is evident based on disability, ethnicity, SES and
geographic region. As one of those factors alone is has been found to impede an individual from
receiving the care they require; it is logical to conclude the aggregate of these factors could
dramatically decreases the number and type of services to which an individual has access. For
children diagnosed with ASD, access to accurate, early detection and intervention is paramount
as many individuals with ASD require a long-term team approach to treatment including
habilitative, medical, educational, and mental health professionals.
Statement of the Problem
Children with autism have long faced disparities in equality of access to needed medical
services since historically these services have not been covered or minimally covered by
insurance. The disparities in access are exacerbated by poverty, ethnicity, and geography.
Growth in prevalence influences the level of demand for health care providers and services.
Increases in the demand for health care contributes to the increase of the overall cost of care for
that diagnosis incurred as well as creating long waitlists to access specialized services and
providers (Stuart, M., 2011; Lavelle, T., et al.,2014; Fifield, J. 2016; Cooper, R, 2014; CMS,
2011; Havens, L.A., 2015; DHHS, 2014; Kaiser Foundation, 2016). Increases in demand for
autism services, a lack of available providers and/or available licensed providers and the rising
costs of health care advanced insurance reform and a revision of the DSM to the foreground of
the 2010-2020 decade. During this period the federal government mandated states pass autism
insurance reform measures (Cooper, R., 2014 2014; Stuart, M. 2011). The autism mandates
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required public and private insurance companies (excluding ERISA policies) to provide some
level of coverage for treatment of ASD (Stuart, M., 2011). These federal mandates were
important to increase access to specialized autism treatments as recommended by health care
providers but not typically covered by insurance due to cost (Stuart, M., 2011). While the
mandates required insurance providers to cover some autism services, the law allowed private
insurance companies to underwrite restrictive access to services using monetary caps, age limits
or visit limits on therapies such as ABA, which are traditionally expensive (Lavelle, T., et al.
2014; Newschaffter, J. and Curran, L., 2003; Vohra, R. et al, Havens, L.A., 2015; Kaiser
Foundation, 2016). These allowances resulted in furthering the existing variations in the type and
number of services covered by the various insurance types (e.g., public, private, government)
acting to further the difficulties individuals of minority, LSES and rural geographic status in
accessing a diagnosing provider (Parish, S.L. et al., 2015; Havens, L.A., 2015; Kaiser
Foundation, 2016).
Concurrent with the mandates, the DSM-IV was criticized as contributing to the overall
prevalence of autism as the expansion of the DSM-III diagnosis criteria was thought to be too
general for providers to make an accurate diagnosis between PDDs (Mazurek, M.O. et al., 2017,
Young, R.L., & Rodi, M.L., 2014, Kulage et al., 2014, Yaylaci, F. & Miral S., 2017, Bennet, M.,
& Goodall, E., 2016, Maenner, M.J. et al., 2014). Under the revised DSM-5, a new diagnosis of
Autism Spectrum Disorders (ASD) was created. The implemented changes were designed to
delineate the presentation of autism signs and symptoms for providers to increase accuracy in
diagnosing (Copper, R., 2012). Yet this reasoning for revising the autism criteria was provided
for revision of the DSM-5 to intent was to increase the accuracy of autism diagnoses and reduce
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over-identification slowing the diagnosis rate (Cooper, R., 2014 2012; Bent, C. A., Barbaro, J., &
Dissanayake, C., 2017; Peters, W., & Matson, J., 2019; Maenner, M. J., et al., 2014). A reduction
of prevalence, however, was not found even as barriers associated with SES, ethnicity, and the
consistent revising of the ASD diagnosis criteria as the prevalence of autism continued to effect
provision of services.
When the prevalence of any diagnoses (such as ASD) increases, utilization and the cost
of care associated with services also increase. Given that health care costs are estimated by
number of diagnosis codes (e.g., autism) utilizing specific services (Cooper, R., 2014 2014), it
can be reasonable concluded the cost of health care services associated with autism will continue
to rise as the prevalence rises. As the estimated prevalence of a disorder influences the
availability of services and providers accessible to individuals it is therapeutically important to
answer the question of why the diagnosed prevalence of autism continues to rise given the
barriers of a strict diagnosis criteria, limited insurance coverage and preexisting conditions.
Purpose of the Study
A diagnosis of ASD is lifelong and affects all aspects of an individuals’ existence from
academics to social activities, and future career opportunities. The treatment of autism frequently
requires multiple, and often intense, therapies yet access to autism treatment has been limited by
ethnicity, geography, socio-economic status and lack of insurance coverage. The autism
insurance mandates increased access to providers and health care services for some but not all
(Douglas, M.D., Benevides, T. W., & Carretta H., 2017, Chatterji, P., Decker, S. L., &
Markowitz, S., 2015, Saloner, B. and Barry, C. 2019, Barry, C. 2019). Accessible health care
services are specifically necessary for individuals diagnosed with ASD as there is an increased
likelihood of co-morbidities (e.g., mood disorder, bi-polar disorder, obsessive/compulsive
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disorder) typically requiring multiple, specialized therapies to meet functional daily living goals
(Barry, C., 2019). However, coverage of autism diagnoses services is not guaranteed based on
the individual’s insurance policy and a diagnosis of autism does not automatically grant access to
therapeutic services due to the variability of insurance coverage, level of socio-economic status,
ethnicity, and geography (Stuart E., et al., 2017, Berlin Baller, J., et al, Wang, L., et al., 2013;
Ngyen, C. T., et al., 2016, Gibson, J et al., 2013). Diagnoses provides access to specific services
hence any changes to diagnostic criteria will have a direct impact on utilization, cost, type, and
amount of services an individual receives (Lavelle, T., et al., 2014, Cooper, R., 2014, 2014). This
is because the inclusionary/exclusionary language of diagnosing criteria and type of insurance
coverage act as a gatekeeper for accessing specialty services. These hurdles lead to questions of
what factors are influencing autism prevalence as the prevalence continues to rise despite the
barriers. This will further the body of research have aimed at examining health disparities for
children with autism. Additionally, examining variable associated with diagnosed prevalence of
autism and type of insurance coverage along with examine the influence of other variables such
as ethnicity, SES, geography and recent visits with a provider study will provide insight into the
probability of a specific type of insurance is significantly related to a diagnosis of autism while
considering the other influencing factors. The information derived from this study has important
implications for policy level when determining to add therapy licensing regulation or
reimbursement rates for providers. Policy changes can then be made at the local, state, and
federal levels regarding coverage/access to services which can influence therapy outcomes for
people with autism (Newschaffter, J. and Curran, L., 2003; Lavelle, T., et al.; 2014 Fifield, J.
2016; Copper, R. 2014). Beyond policy change, analyzing the variables associated with
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insurance related to the prevalence of autism will assist providers in accurately identifying
individuals with autism as insurance coverage is key to accessing diagnosing providers. If
specific insurance types are found to be associated with a diagnosis of autism, this could suggest
individuals do not have access to the diagnosing providers and thereby skewing the actual
prevalence of autism and influencing the level of utilization and overall cost of care.
Research Questions
An initial study’s (Thompson, J. 2018, The Prevalence of Autism on a National Scale
following the changes to the DSM-5. Unpublished Manuscript. Western Michigan University),
findings did not support previous research studies which predicted a 30% decrease in the
prevalence of autism as a result of the stringent DSM-5 diagnosis criteria (Anderson, C.,2012;
Peters, W., & Matson, J., 2019; McPartland, J., 2012; Bent, C. A., Barbaro, J., & Dissanayake,
C., 2017; Mazurek, M.O. et al, 2017; Yaylaci, F., &Miral, S., 2017; Bennett, M., & Goodall, E.,
2016; Maenner, M.J. et al., 2014; Young, R.L. & Rodi, M.L., 2014; and Lobar, S.L., 2016).
When national data was examined, a significant change in the domestic prevalence of autism was
not found. This study continued the previous investigation and extended the questions that
surfaced after not finding a significant change in the prevalence of autism diagnoses. This study
was designed to answer two questions 1) “Is there a change in proportions of insurance coverage,
visits to a provider, geographic region, ethnicity, and socioeconomic status over time and is it
significant?” and 2) “Are specific insurance types such as Medicaid, Tricare, and Private,
associated with the diagnosed prevalence of autism following the changes to the DSM-5 and the
implementation of the autism insurance mandates for the years 2010 and 2018?”.
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Significance of the Study
Children diagnosed with autism face a multitude of health care challenges. One of which
is finding health care providers who are licensed in the individual’s state and understand the
complexity and course of autism disorders (CMS, 2011; Havens, L.A., 2015; DHHS, 2014;
Kaiser Foundation, 2016). These challenges are exacerbated when ethnicity, socio economic
status and geography are considered (Lello, A., Frazier, T., Dixon, P. J., Shih, A. J., & Karpur,
A.,2019; Dougherty, D. et al., 2013; Magaña, S. et al., 2012; Park, C. et al., 2014 ). The

additional challenge of limited access to care due to incorrect estimations of the prevalence of
autism will only continue to further health disparities. Health care policy, insurance coverage,
allocation and distribution of services are tied to diagnosis codes. Diagnosis codes provide access
to specific interventions linked to those codes (e.g., ASD codes provide respite and monetary
assistance to families). Yet access to autism services have been historically limited by a lack of
insurance coverage, geographic area, ethnicity, and SES. Inaccurate estimations of autism
prevalence influence the utilization of resources increasing the possibility some individuals will
not be able to access a diagnosing provider (Ngyen, C. T., et al., 2016; Parish, S. L., Thomas, K.
C. ., Williams, C. S. ., & Crossman, M. K., 2015; CMS, 2011; Havens, L.A., 2015; DHHS,
2014;Kaiser Foundation, 2016). Without access to providers the possibility to meet positive,
functional outcomes becomes reduced; manifesting in decreases in educational performance and
poorer social relationships (Coombes, J. et al., 2018; Glassgow, A.E., & Van Voorhees, B, 2017;
Christensen, D. L, et al., 2016). Determining reasons for the continued rise in the prevalence of
autism, when barriers such as insurance coverage and diagnosis criteria restrict access will assist
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health care providers, policy makers and insurance providers to better understand how to impart
individuals with the most effective autism services needed to experience increased quality of life.
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CHAPTER II
LITERATURE REVIEW
The Relationship between Autism and Insurance
Autism is life-long and most often accompanied by other co-occurring morbidities such
as: bipolar disorder, mood disorders, gastrointestinal problems, and sensory disorders (Karpur,
A., et al, 2018, Cooper, R., 2014 2014). Individuals diagnosed with ASD frequently require
multiple, specialized care. The cost of specialized care over a lifetime is around $2.4 million per
person (Saloner, B., and Barry, C., 2019; Stuart, M. J.D., 2011). The continued increase in the
diagnosed prevalence of autism has influenced the demand and utilization of autism related
health care services. The lack of or limit of insurance coverage for autism related services has
created challenges for individuals and their families not just in accessing therapies but in being
able to access a provider who can diagnose an Autism Spectrum Disorder (Saloner, B., and
Barry, C., 2019, Wang, L., et al., 2013, Barry, C., 2019).
Prior to the implementation of the ACA many insurances were less likely to cover
therapy services for a child with autism. In response to public push for increased access to autism
services and rising costs of health care, the federal government mandated states write legislation
instructing insurance companies to cover evaluation and treatment for autism. The autism
mandates included coverage for behavioral therapies (e.g., ABA), functional therapies (e.g., ST,
OT) and other mental health services. The intention was to lessen health care disparities between
individuals with autism and individuals with other disabilities. A result of expanded coverage
was access to early intervention services for some but not for all (Douglas, M.D. et al., 2017;
Ngyen, C. T. et al., 2016; Zeleke, W., Hughes, T., and Drozda, N. 2019; Yingling, M., Hock,
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R.M., and Bell B., 2018; Thomas, K. et al., 2012; Stuart, E., et al., 2017; Berlin Baller, J., et al,
2016, Karpur, A., et al, 2018). Within a few years of the mandates, multiple studies found the
mandates had a greater positive overall effect of increasing access to therapies under public
insurance options (e.g. Medicaid) compared to private insurance options (e.g., Aetna) (Parish
S.L. et al., 2015; Barry, C. 2019; Thomas, KC., Williams, CD., and DeJong, N., 2016). The
mandates also were found to reduce out-of-pocket costs for individuals with public insurance
which contrasted with the high out-of-pocket costs experienced by individuals with private
insurance (Parish, S.L., 2015, Saloner, B., and Barry, C., 2019; Wang, L. et al., 2013).
While the mandates did have positive effects on public insurance coverage, the mandated
legislation was limited to public and private insurances, employer-based policies and privately
purchased policies through open markets. This excluded ERSIA policies (e.g., companies who
ensure their own workers and some small businesses). The language in the legislation gave
insurance companies the freedom to create restrictive monetary and age caps whilst it granted
states the right to set its own mandate laws in accordance with the Federal law.
The allowance for some insurance policies to be excluded from the mandates along with
flexibility of what services are covered under an insurance policy created a potential for further
disparities because of the differences in coverage which directly impacted access to services
(Stuart, E., et al., 2017, Berlin, J. et al., 2016, Douglas, M.D. et al., 2017). When examining
private insurances, Aetna, for example, requires a preauthorization (e.g., a request from a
provider to an insurance company for permission to provide services) before the insured can
schedule an autism evaluation. The ASD evaluations are only approved as “medically necessary”
if those with signs/symptoms exhibited have persistent difficulties in the areas of language,
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social skills and the like across multiple contexts as noted in the DSM-5 autism diagnosis criteria
(Aetna, 2019).
For individuals covered under United Healthcare®, autism coverage specifies that an
individual diagnosed with autism can only receive speech therapy if it has been deemed as
medically necessary by a physician or psychologist. United also implements limitations on the
number of therapeutic visits an individual can receive from each therapy discipline (e.g., ST, OT,
and SW). United, like Aetna, also has the provision of allowing employers and direct policy
purchases the ability to choose their level of coverage some of which significantly limit autism
services (United Healthcare®, 2020). Blue Cross Blue Shield of Michigan covers autism
services until the age of 18, through customizable employer offered policies. The customization
allows for limitation on coverage and can limit coverage or require high co-pays/deductibles
(BCBS Michigan, 2019). Unlike United and Aetna, Blue Cross Blue Shield requires an autism
evaluation be conducted at an authorized Autism Evaluation Center (ACE) by a comprehensive
evaluation team (e.g., psychology, OT, MD, ST, etc.) where many other insurances require an
evaluation from a psychologist/psychiatrist or MD (BCBS Michigan, 2019). The requirement of
families having to schedule an autism evaluation at an accredited center creates barriers in wait
time and a possible lack of providers (depending on the geographic area) (Marcin, J.P., Shaikh,
U., Steinhorn, R.H., 2016).
In comparison, Medicaid coverage guidelines state that Medicaid should “address the
specific service needs of any individual but it must be medically necessary” (Havens, L.A.
2015). Under these guidelines states may cover autism services under different categories such as
“section 1905 (a)(6) other licensed practitioners; 1905(a)(13)(c) preventive services and

29

1905(a)(10) therapy services” (DHHS, CMS, 2014). These guidelines allow for states to choose
how they will allocate monies to reimburse providers for Medicaid autism services. The
flexibility in how to cover autism treatment creates challenges for both providers and
families/individuals as Medicaid requires therapists to be licensed in a state to provide services
(DHHS, CMS 2014). A problem arises when there is a demand for autism services in a state, but
that state has not adopted regulations for Medicaid licensed providers. This significantly reduces
the availability of providers able to address the autism needs in that state (DHHS, CMS, 2014).
For example, Texas previously refused to cover ABA services as the state did not implement
regulations to establish ABA licensing under Medicaid. The Texas state government responded
to criticism for its lack of Medicaid autism coverage that Applied Behavioral Analysis (ABA)
treatments were not specifically mandated as having to be covered, therefore they (Texas) did
not to have establish regulations for ABA providers to practice in the state (Kaiser Family
Foundation, 2016). States refusing to establish therapy licensing/regulations creates significant
obstacles for individual to access diagnosing providers.
An additional problem with state’s rights in implementing the Medicaid autism expansion
are some state’s low Medicaid reimbursement rates. A Pew research study from 2013 found
physician’s acceptance of new patients with Medicaid was lower than Medicare or private
insurance, especially in states with lower Medicaid payment rates (Ollove, M., 2018). As of
2018, Medicaid only reimbursed providers 72% of what Medicare pays for the same services
(Ollove, M., 2018). When reimbursement rates are low, it can cause providers to not accept
Medicaid patients as well inhibit the attraction of qualified providers to that geographic area. A
lack of available, licensed and/or qualified providers creates longer wait times or requires
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traveling long distances for care (Ollove, M., 2018). These variations with Medicaid coverage
and licensing of providers in different states create significant barriers for families to access
diagnosing providers, even when Medicaid insurance is present.
Variations between insurance coverage occur on a large scale, but variations in insurance
coverage also exist at the micro level with the frequency with which an individual receives
services (Monz, B.U., 2019; Thomas, K et al., 2012; Nuyen, C. T., 2016; Zeleke, N., et al., 2019;
Karpur, A. et al., 2018). People with public insurance coverage receive 15 hours (or less) of
direct therapy services per week but reported access to a wider variety of therapies as compared
to individuals with private insurance. Whereas private insurances holders reported restrictions to
accessing services but experienced a higher frequency of direct services once services were
initiated (Nuyen, C. T., 2016, Wang, L., et al., 2013; Saloner, B, and Barry, C. 2019; Douglas,
M.D., et al., 2017). The variation in the frequency of services directly impacts the ability of an
individual to make the best gains and achieve the most optimal outcomes (Bennett, M., &
Goodall, E.; 2016; Zwaigenbaum, L., et al., 2015; Newschaffter, J. and Curran, L., 2003).
These highly variable differences in insurance coverage have been also found to occur at
the state level as each state can create laws for coverage equitable to the minimum coverage
provided by the federal government. While this practice isn’t unique to autism disorders, the
historical restrictions in coverage and access to care are lessened by these practices. For example,
in Alabama, ASD therapies are limited to what is prescribed by the PCP, and not necessarily the
treating therapist. Alabama also established a limit on insurance coverage of $36,000.00
maximum benefits per year (Alabama Legislature, 2012). In Michigan, however, coverage for
treatment is no longer available after the age 18. To add to this, the law also stipulates that the
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monetary coverage for therapies will decrease every 6 years beginning at age 6 (Michigan
Legislature, 2012). In Colorado, autism treatment plans must be approved and/or developed by a
“licensed physician or a licensed psychologist” and the treatment plan must be developed within
the patient’s medical home and any recommended follow up treatment must be prescribed by an
M.D. or a licensed psychologist (Colorado, C.R.S. 10-16-104, 2012). These allowances can
become barriers for the financially struggling to gaining access to autism services.
Analyses comparing insurances have found the type of insurance coverage directly
influences how much care and what type of care an individual is entitled to receive as people
with public insurance received less therapy per week compared to private insurances (cite). The
problem with insurance restrictions/limitations is that most individuals don’t choose their
insurance provider or policy as it is usually chosen by an employer or through what they receive
from Medicaid. In other words, most individuals do not get to choose what their insurance policy
covers only the level of coverage from employer chosen options. When families must purchase
insurance privately it places children living in and around the poverty line at a significant
disadvantage with lower socio-economic families being more likely not to have insurance
coverage and/or have pay for services out-of-pocket (Coombes, J. et al., 2018; Rosen-Reynosos,
M. et al., 2016; Nuyen, C. T., 2016, Wang, L., et al., 2013).
Variations in health care coverage create barriers for some and easier access for others;
creating confusion and difficulty for families/patients trying to navigate health care systems. Due
to these barriers it’s not unusual to find clinicians in other areas of mental health services
engaging in “workaround” practices. Workarounds occur when a service provider assigns a more
severe or different diagnosis to allow the patient to gain access to service(s) they would not
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normally receive (Wynia, M. K. et al., 2000; Whooley, O., 2010; Kirk, S.A., & Kutchins, H.
1988; Rushton, J.L. et al., 2002; Rappo P.D. 2002; Braun, S.A. & Cox, J.A. 2005; Johnson, C., et
al., 2007; Kogan, M.D. et al. 2012) Provider trend analyses have shown providers favor a few
diagnoses they view as “helpful” for their patients. Anecdotal evidence from a 2012 study (Lord
et al., 2017) supported as the authors suggested a diagnosis of Asperger’s was dependent upon
the clinic and/or provider the patient visited. Assigning a diagnosis to be “helpful” situation is
problematic because if a diagnosis is based on the context versus presentation of symptoms, then
the reliability and stability of a diagnosis are affected yielding no standard; thus: providers can’t
be sure they are accurately prescribing the necessary course of action (Cooper, R., 2014, 2012).
Autism and the DSM
At roughly the same time the federal mandates were passed, the DSM underwent a 5th
revision. Since autism’s introduction to the DSM the diagnostic criteria have been
revised/refined with every updated release of the DSM. The trend was continued with the 5th
edition/revision as the of the DSM criteria for diagnosing Autistic Disorder (AD) was again
revised. The proposed changes were so significant they drew both positive and negative
attention. Proponents of the changes argued the DSM-IV diagnostic criteria was too broad and
the broadness might be contributing to some of the increase in the prevalence of Autism and
therefore a change was needed (Copper, R., 2014). Those lobbing for changing the autism
criteria made the case that the DSM-IV was not specific enough in its ability to accurately draw
distinctive conclusions among Pervasive Developmental Disorder (PPD) /PDD-Not Otherwise
Specified (NOS), Asperger’s (AS) and AD (Williams et. al., 2008). It was speculated the lack of
ability to differentiate between PDDs could also be contributing to the rise in prevalence as
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children with true PDDs and AS were being over identified as having autism (Williams et. al.,
2008). Advocates concerned with the rising costs of health care argued that changing the criteria
could help to slow the prevalence which could decrease utilization and thereby influence cost
(Cooper, R., 2014, 2014; Harmon, A., 2012, Kupfer, D., First, M., & Egier, D., 2002; Kupfer D.,
2012; Verhoeff, B., 2010). As a result of public persuasion, political climate and the increasing
costs of health care, the decision was made to modify the autism diagnosis criteria again as a
means of increasing accuracy in the diagnosis of autism (Peters, W., & Matson, J., 2019;
McPartland, J. 2012; Worley and Matson 2012; Cooper, R., 2014, 2014).
The changes made to the autism diagnosis in the DSM-5 revision were controversial as
the criteria for diagnosing autism no longer distinguished among the previous diagnostic
subcategories of PDD, PDD-NOS, Asperger’s Disorder (AS), and Autistic Disorder (AD), as
stand-alone diagnoses in the DSM-IV. Instead, AD, AS and the PDDs were replaced with a new
diagnosis of “Autism Spectrum Disorders” (ASD) in which observed/reported symptoms are
rated along a continuum and assigned a level of severity (1= Mild, 2= Moderate, 3 = Severe)
(DSM-5, 2012).
The resistance to the removal of Asperger’s as a diagnosis was relatively fervent as
Asperger’s had developed a strong cultural and community identification around the diagnosis
and its uniqueness from Kanner’s “Classic Autism” (Cooper, R., 2014). Those against its
removal argued that Asperger’s was still a “new” diagnosis (only established in 1994); therefore,
it was still too new to appropriately make claims confirming or discounting its existence as a
separate diagnosis (Cooper, R., 2014). Other practitioners expressed fear the reduction of the
separate disorders into a single category would downplay the biological heterogeneity of the
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syndrome (Silverman, C., 2011). Further concern was voiced by patients and advocates that the
removal of Asperger’s as a diagnosis would result in a loss of a diagnosis and access to therapies
(Stuart, E., et al., 2017, Berlin, J. et al., 2016, Douglas, M.D. et al., 2017). The potential for loss
of a diagnosis was a valid concern since the diagnostic methods traditionally used to diagnose
Asperger’s were inconsistent making an arrival at an accurate diagnosis difficult. These
inconsistencies and differences in the characteristics of AS led clinicians to employ a greater
amount of clinical judgement when attempting to differentially diagnose PDDs (Silverman, C.,
2011; Lai, M.C. et al., 2014; Cooper, R., 2014). Arguments for and against the removal of
Asperger’s as a separate diagnosis were most often based on the individual’s clinical view of the
nature of Asperger’s. People who viewed Asperger’s as a distinct syndrome separate from autism
requiring unique and specific interventions were mostly against the change (Silverman, C., 2011;
Lai, M.C. et al., 2014; Cooper, R., 2014)). Others, who believed Asperger’s was a “higher
functioning” form of autism, were in support of its removal (Silverman, C., 2011).
Given the amount of push back over the significant changes prior to its release, several
studies comparing the AD (DSM-IV) and ASD (DSM-5) diagnostic criteria were conducted
during the DSM-5 field trials. When the DSM-5 criteria were applied to cases of autism
diagnosed under the DSM-IV, researchers found an average of a 30% reduction in ASD
diagnoses (Anderson, C., 2012; Peters, W., & Matson, J., 2019; Maenner, M. J., et al., 2014;
Halfon N. and Kuo AA., 2013). The studies speculated that due to the strict criteria of the DSM5, individuals previously diagnosed with PDD/NOS and Asperger’s were less likely to meet the
criteria for mild levels of ASD under the DSM-5 (Anderson, C., 2012; Worley and Matson 2012;
Maenner, M. J., et al., 2014; Kulage et al. 2014).
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Not all previous comparison studies between the DSM-IV and DSM-5 reported there
would be a reduction in prevalence. Several studies found the DSM-5 to be equitable while more
specific than the DSM-IV. These studies suggested that due to the provisions written in the
DSM-5 criteria, individuals with a historical diagnosis of AD would maintain a diagnosis of
ASD after the change (Silverman, C., 2011). It was also speculated if a diagnosis of ASD wasn’t
maintained the new diagnosis of Social Communication Disorder (SCD) would be sensitive
enough to capture individuals previously diagnosed with Asperger’s and PDD’s allowing for
therapy to continue under a different diagnosis (Cooper, R., 2014).
However, the SCD diagnosis is not without its’ criticism. One of the main arguments
against the diagnosis is that it is difficult to capture mild forms of pragmatic deficits and the SCD
criteria focuses on specific pragmatic language abilities versus all language abilities which
autism specific instruments evaluate (Cooper, R., 2014). Another factor working against SCD as
an alternative diagnosis is that social communication deficits are often accompanied by
comorbidities causing difficulties in differential diagnoses (Brukner-Weirtman, Y., et al. 2016;
Huerta et al. 2012). Like the AS diagnosis criteria, there are not a large array of standardized
tests to accurately assess SCD meaning clinicians must rely on clinical judgement to reach a
diagnosis (Rushton, J.L. et. al, 2002).
Several other criticisms of the addition of the SCD diagnosis were noted prior to its
release in the DSM-5. First, the language used in the criteria for diagnosing social
communication disorders is problematic as the definition uses vernacular not equal to the
wording used in the previous diagnosis definition of PDD/NOS (Brukner-Weirtman, Y., et al.
2016). Second, is the use of the long-standing “gold standards” of protocols used to diagnosis
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autism; the Autism Diagnostic Observation Schedule (ADOS-2) and the Autism Diagnostic
Interview-Revised (ADI-R). These assessments have been found unable to differentially
diagnose SCD from ASD when used alone. It has been reported that clinicians in the field often
administer only one of the two assessments (Brukner-Weirtman, Y., et al. 2016; Gibson, J. et al.
2013; Foley-Nicpon, M. et al. 2017). Finally, the pragmatic communication skills needed to meet
the criteria for SCD are based on higher level language skills which do not manifest in children
until ages 4-5 (Foley-Nicpon, M. et al. 2017) two years after ASD can be reliably diagnosed
(Bennett, M., & Goodall, E.; 2016; Zwaigenbaum, L., et al., 2015; Newschaffter, J. and Curran,
L.,2003).
A true SCD diagnosis is difficult to reach due to the lack of sufficient diagnostic
instruments as well as the ambiguity surrounding the language of an SCD diagnosis. This means
that there is a reliance on clinical judgement which is subjective and open to bias (BruknerWeirtman, Y., et al. 2016 and Foley-Nicpon, M. et al. 2017) and could lead to SCD becoming a
diagnosis of convenience for people who don’t “fit” into an ASD diagnosis (Skuse, D.H. 2012).
The Statistical Problems with the DSM
The removal and addition of diagnoses to the DSM raised questions regarding the
comparability between versions (Cooper, R., 2014). Anecdotal evidence from epidemiology
studies have suggested that with each change to the diagnostic criteria could be attributed to
some of the rise in autism since the 1990s (Cooper, R., 2014). A comparison study applying the
DSM-IV autism diagnosis criteria to an original autism data set circa 1970 found when the
DSM-IV was applied to this data set, the prevalence of autism was three times higher than the
original rate from 1970 (Silverman, C., 2011). These results suggest each time the criterion for
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autism is modified, more children are found to have autism. Due to the significant changes
between DSM versions researchers claimed the estimation of ASD prevalence could not
accurately be calculated for the DSM-5 using the DSM-IV criteria because the characteristics of
autism were given greater prominence in the DSM-5 as compared to the DSM-IV (Silverman,
C., 2011; Cooper, R., 2014); ergo an accurate comparison could not be made between the two
versions because of the differences in analysis, construction and changes to diagnostic criteria
(Cooper, R., 2014). Not to compare versions of DSM was the conclusion reached by the revision
committee who determined a 1:1 comparison between the DSM-IV and DSM-5 would be “too
cumbersome” to complete because of the magnitude of those types of comparison studies
(Cooper, R., 2014). While a 1:1 direct comparison may be difficult due to changes in criteria, the
reliability information would be useful to providers who are expected to make accurate diagnosis
on a regular basis (Cooper, R., 2014).
Comparing versions of the DSM is also made problematic due to the inconsistent
interpretation of inter-rater reliability (Cooper, R., 2014). The DSM has long utilized Cohen’s
kappa values as a standard statistical analysis of the inter-rater reliability of each version of the
DSM (Cooper, R, 2014). Kappa values refer to the chance two clinicians will agree on a
diagnosis when implementing the same criteria; a value of 0 indicates a chance agreement and a
value of 1 indicates perfect agreement. When standardizing criteria, the greater the kappa value
the more confident providers can be in giving an accurate diagnosis which influences the
demand, utilization and cost of services Cooper, R., 2014 2012; Bent, C. A., Barbaro, J., &
Dissanayake, C., 2017; Peters, W., & Matson, J., 2019; Maenner, M. J., et al., 2014). The
variability in the interpretation of kappa values can make direct comparisons between versions of
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the DSM difficult. What has been considered a “good” kappa value has significantly changed
since the addition of Autistic Disorder in the DSM-III. The DSM-III had a kappa value of .7
which, at the time, was considered the threshold for “good agreement” (Cooper, R., 2014). This
interpretation was in alignment with the kappa values for most other mental health disorders such
as schizophrenia and affective disorders which had kappa values of .8 (Silverman, C. 2011).
The 5th revision saw a change in the way the kappa values have historically been
interpreted. Interpretations of kappa value ranges were adjusted for the change to the DSM-5.
Instead of .7-.8 being the threshold for what was “good”, values of .8 were considered
“miraculous”, values of .6-.8 were “cause for celebration”, values of .4-.6 were “realistic” and
values of .2 -.4 were “acceptable” (Cooper, R., 2014). A kappa analysis of the entire DSM-5 was
conducted, and it was found to have an average kappa value of .4. This was a significant
decrease from the DSM-III and IV which had values of .7 (Cooper, R, 2014). Moreover, when
specific disorders from each version the DSM were compared head-to-head, all the major
affective disorders with kappa values of .8 in the DSM-III were found to have kappa values of
.28 in the DSM-5 (Cooper, R., 2014 2012). Additionally, of the 20 new diagnoses added to the
DSM-5, only 3 were found to have kappa values of greater than .6 (Cooper, R., 2014, 2012).
The change and varied interpretation of kappa values points to a larger problem with the
reliability of DSM. As there is not a universally agreed upon standard of what is considered an
acceptable kappa value among researchers. For example, at the time of the DSMs III and IV,
Robert Spitzers’ standards or Landis and Koch’s standards (1977) were mainly utilized. These
standards ranked kappa values of .2-.4 as “fair”, .41-.6 “moderate”, .61-.8 “substantial” and .81
as nearly “perfect” (Cooper, R., 2014). Later in the 90’s, kappa values below .2 were interpreted
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as “poor” and anything above .61 was interpreted as “good” (Cooper, R., 2014). Then in the
early 2000’s, Fleiss, Levin and Cho Paik theorized kappa values below .4 were “poor”, .4-.75
was “fair” and anything above .75 was “excellent” (Cooper, R., 2014). This lack of consistent
interpretation leaves too much variation which has direct implications on prevalence as it does
not allow for a true comparison between diagnosis criteria. This again creates difficulties for
providers arriving at an accurate diagnosis upon which access to services are dependent.
Differential Diagnosis in Early Years
The task of attempting to differentially diagnosing autism from other developmental
conditions is difficult for even seasoned professionals because conditions, such as genetic
disorders (e.g., Down syndrome, stunted growth, and developmental abnormalities), present with
characteristics like ASD yet the causes are not related to autism (Johnson, C., et al., 2007). There
is a thin line when attempting to differentially diagnose autism from similar developmental
disorders (DDs) such as a cognitive impairment (CI) as compared to attempting to differentially
autism as a co-occurring disorder when other developmental disorders are present (e.g., autism
and cognitive impairment). The presence of similarly appearing disorders, such as CI, can also
manifest with global developmental delays and non-compliant behaviors (e.g., kicking,
screaming, hitting as a means of protesting) causing providers to assign a diagnosis of autism as
the primary condition when it in fact, is not (Johnson, C., et al., 2007). The difficulty in
accurately differentially diagnosing autism from other developmental disorders can lead to
inaccurate estimations of prevalence which influences the availability and utilization of services
and providers.
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Shifts in Provider Perception
Another factor which could be influencing the diagnosis prevalence rate could be a shift
from provider centered patient care where the provider directs medical decisions for the patient
to care which is centered on the patient. In the patient centered model of health care,
patients’/families’ wants, feelings and beliefs are taken into consideration by providers when
making a diagnosis (ASHA, 2020). Considering patients’ wants can embolden parents/patients to
request providers to assign a diagnosis of autism to access specific services (Cooper, R., 2014).
The change form clinician centered to patient centered care also reflected the changes in parental
and societal attitudes regarding autism. Through the 1940s, 50s and 60s, a diagnosis of autism
(as most mental health disorders) was viewed as something of which to be ashamed and the
result of “cold parenting” methods (Silverman, C. 2011). Families were less likely to seek out a
diagnosis of autism because of the stigma associated with the disorder. increases in research,
education of the signs and symptoms of autism, sensitive early identification assessments, and
advocacy for autism have changed the overall public perception of autism to one which is more
accepting of the disorder (Cooper, R., 2014). As autism has become accepted and the mandate
for autism insurance coverage has been implemented there are increased numbers of parents
/individuals who will advocate physicians for an autism diagnosis to access habilitative and
mental health services (e.g., ABA services) which might not be covered under other
developmental delay diagnoses (e.g., speech and language delay) (Rose, Roderick A, et al., 2010;
Silverman, C., 2011; King, C., 2016; Zeleke, W., Hughes, T., and Drozda, N., 2019). If providers
only consider individuals wants without considering the presentation of symptoms this will
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contribute to an overabundance of people incorrectly diagnosed with autism taking away services
from people who truly do have an autism spectrum disorder.
Increases in Awareness in Education
Public understanding of autism has increased through awareness, advocates and research
has changed the way autism is viewed in education. Prior to 1990, AD/ASD was not included in
the Individuals with Disabilities Education Act (IDEA). Before inclusion in special education
eligibility, children exhibiting severe forms of developmental impairment were typically given
the eligibility label of cognitive (CI) or emotionally impaired (EI) to access behavioral and
communication services (Johnson, C.P. et al, 2007). The action of adding ASD to Special
Education Eligibility increased the importance of the role of schools in identifying children with
autism as school ASD eligibilities account for 75% of all the ASD cases in the U.S (McGrath, K.
& Mann, M. 2020).
While an eligibility of ASD for special education differs from a medical diagnosis it still
accounts for increases in prevalence. This is due to shifting the burden of autism identification to
educational entities as children who do not have access to medical care and/or insurance
coverage are often diagnosed with autism once they reach school age and are identified by an
Interdisciplinary Education Plan (IEP) team (Johnson, C. et al., 2007; Kogan, M.D. et al., 2007).
This is also partially due to the refusal of insurances to cover habilitative therapy services as
insurances have denied claims on the terms habilitative services could be provided by the school
district (Johnson, C. et al., 2007). As the burden of identification is placed on educational
systems any increases in autism will directly impact special education funding (e.g. the need for
1:1 paraprofessional, behavior assistants, staff training, modifications to the environment, etc.)
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(Kogan, M.D. et al., 2007) as Special Education funding is based on the number of students who
are enrolled and required additional assistance.
Culture
Cultural/racial factors may also have an influence on the prevalence of autism as
minorities have experienced significant racial disparities across all health outcomes (Magana, S.
et al., 2012, Dougherty, D., et al., 2013). On average, children from minority families use far less
health care and mental/behavioral health services as compared to children from Caucasian
families who are also far more likely to have access to preventative care and screening services
(Coombes, J. et al., 2018; Fulkerson, N. et al., 2017, Dougherty, D., et al., 2013). In general, the
differences between ethnic groups are significant as children from Black and Latino families
have been found to have poorer mental health outcomes, live in lower socio-economic (LSES)
households, and are enrolled in public insurance even when insurance coverage, income, age,
and severity are held constant (Magana, S. et al., 2015; Calvo, R et al., 2015). Among all
minorities, immigrant families are less likely to be aware of the health care services in their
communities and more likely to not hold insurance (Calvo, R. & Hawkins, S., 2015). Immigrant
families also face the difficulty of language barriers when interacting with providers (Fulkerson,
N. et al., 2013). Only 20% of Spanish speaking individuals have access to health care leaving
around 80% of the Spanish speaking population without resources to well-child visits which are
required to gain referral for specialty providers (Fulkerson, N. et al., 2013).
When comparing the utilization of health care services among racial groups, black
families were less likely to have a PCP and Latino families were less likely to have coordinated
care (Park, C. et al., 2014; Magana, S. et al., 2012; Xiaoxin, K. et al., 2017, Dougherty, D., et al.,
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2013). The lack of a PCP and coordinated care causes difficulties for minority families as it
hinders the ability to gain referrals required for a special evaluation for disorders such as autism
and subsequent therapeutic intervention(s). The health disparities are further compounded in
minority children diagnosed with ASD as they have less access and greater difficulties accessing
specialty care compared to any other developmental disabilities (Magana, S. et al., 2012;
Christensen D., et al., 2012).
Cultural perceptions which individuals and their families hold regarding health care in
general have also been found to influence health care outcomes in minorities. Traditionally
minorities have reported negative views of mental health disorders and consider them to carry a
stigma. Cultures which view mental health (and illness in general) as a punishment from a higher
power are less likely to seek a diagnosis/treatment because of stigma and beliefs (McLaughlin, L.
& Braun, K., 1998, Wong, E. C. et. al, 2017, Razi, R.R. 2017; Quazi, S. et. al, 2008, Koening,
BA & Gates-Williams, J. 1995, Eylem, O., et. al, 2020, SAMSA, 2015, Wong, E.C., et. al,
2017). Negative perceptions of mental health disorder exist at higher levels among Latino (84%),
Black (61%) and Asian (86%) populations which have reported prejudice associated with mental
health disorders (Wong, E. C. et. al, 2017). In addition, and increased percentage of Latino
(42%) and Black (35%) people specifically reported they would put off seeking treatment for
mental health difficulties due to the perceived stigma (Wong, E.C., et al, 2017; Langellier, B. A.
et al., 2016). These negative views of health care act as additional barriers causing delays in care
or delay in management of the disorder.
Misconceptions regarding ethnic culture by providers have consistently reported by
minorities stating their PCP was not sensitive to, understanding of, or respectful of their cultural
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considerations (Calvo, R. & Hawkins, S., 2015). These perceptions were not unfounded as
studies examining health care provider behaviors demonstrated providers had lower expectations
of Latino and Black families compared to Caucasian families. It was found that providers made
fewer referrals for their minority patients and have lower quality interactions with minority
children diagnosed with DDs (Magana, S. et al., 2015; Calvo, R. & Hawkins, S., 2015).
Lack of access to health care services, historical racism, stigma of metal health disorders
and a lack of coordination of care for services have long been obstacles minority children have
faced when attempting to access health care providers and services. These systemic issues are
worsened when the child also is born with a DD and requires access to specialty care. The delay
in or lack of seeking care has resulted in minority children being more delayed in the age of their
first autism diagnosis as compared to Caucasian children (Christensen, D. et al., 2012). Access to
providers is important as the age of a first diagnosis influences, when and if, comprehensive
evaluations are completed. Completed evaluations result in referrals to special therapies, which
without a formal diagnosis cannot be accessed (Christensen, D. et al., 2012). Again, many
minorities are underrepresented in health care due to a lack of insurance/access and the stigma of
mental health disorders the actual prevalence of autism could be significantly larger. To
appropriately maximize autism service utilization all people with autism need to be accurately
identified through access to well-child visits.
Socioeconomic Status and Health Care
Children born into poverty have long been at risk for being born with developmental
delays (Simon A. et al., 2013, Becker, G. & Newsom, E. 2003, Adler, N. & Newman, K., 2002,
Volberding, J., 2018, Razi, R.R., 2017). A person’s socio-economic status (SES) is directly
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related to insurance status as lower SES families are more likely to be uninsured and/or more
likely to have Medicaid insurance (Kuang, X. et al., 2017; Becker, G. and Newsom, E 2003,
Razi, R. R., 2017, Kuang, X., et al., 2017). LSES families have experienced less access to
medical care/therapies compared to families of middle and upper socio-economic statuses
(Alder, N. and Newman, K. 2002). Less access to health care means that LSES households are
also less likely to engage in routine check-ups with a PCP (Fulkerson, N., et al., 2013; Glassgow,
A.E. and Van Voorhees, B., 2017). In comparison, children from higher SES families are more
likely to have insurance, be able to afford care, be enrolled in private insurances through
employment, and have an established medical home. Access to a medical home is important as it
provides a child with comprehensive primary care and acts as a coordinator for gaining access to
other therapeutic interventions (Magaña, S., Parish, S.L., & Son, E. 2015; Park, C., et al., 2014;
Fulkerson, N., et al., 2013; King, C., 2016; Langellier, Brent A, et al., 2016). Families living at
or below poverty are less likely to have a medical home which has been shown to have a
significant influence on access to health care services (Kuang, X. et al., 2017; Park, C., et al.,
2014, Dougherty, D., et al., 2013, Xiaoxin, K., et al., 2017).
When attempting to navigating the landscape of health care, lower SES families have
reported more difficulties and are less likely to seek out a provider for care. Whereas middle to
high SES families are more likely to seek out providers for a diagnosis (Razi, R. R., 2017; Lello,
A., et al., 2016). As noted earlier, the shift to patient centered care helped promote patient
advocacy for access to preferred, required and/or unattainable services. Levels of patient
engagement in advocacy are determined by socio-economic factors where those with the ability
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to afford/access specialty services are the ones who are more likely to advocate for and receive
services.
SES levels can also influence where an individual can receive care. Lower SES families
typically must receive care in under-funded areas with less access to specialty providers as
compared to middle to high SES families (Becker, G. and Newsom, E., 2003). This situation is
troublesome as increased levels of poverty are associated with higher odds of having a probable
developmental delay with accompanying emotional and attention disorders (Simon, A.E. et al.,
2013). Yet 60% of all children under 6 years old, living less than 100% below the FPL are
unable to see a health care provider regardless of having a higher prevalence of mental health
disorders (Volberding, J. 2018).
The ACA implemented mandates for preexisting conditions, such as autism, but it also
expanded Medicaid. The expansion of Medicaid was very important for LSES families as the
prevalence of people who are under insured has been greater than the prevalence of people who
do not have insurance (King, C., 2016). The Medicaid expansion extended coverage to LSES
families/individuals who hadn’t qualified for Medicaid services in previous years due to income
limits. Families at this socio-economic level were often left without insurance because it was not
provided through their employment, or it was too expensive to independently purchase (King, C.,
2016). The Medicaid expansion was positive for many LSES children with developmental
disabilities who are more likely to utilize Medicaid services (Prokup, J., et al., 2018). The
Medicaid expansions were not expansive enough to include all LSES families leaving many to
continue to experience poorer health outcomes, utilize more specialty services and have
increased barriers to accessing care (Prokup, J., et al., 2018). As with cultural barriers, families
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living at or below the FPL may be underrepresented in the national prevalence due to the lack of
access to diagnosing providers. Again, a lack of representation affects the estimation of the use
and cost of limited and expensive autism services.
Health insurance is a strong predictor of whether an individual will have access to health
care services as the under and non-insured continue to face significant barriers in obtaining
health care (King, C., 2016). Yet, having insurance coverage does not ensure access to services,
it may also come in the form of high deductibles, limited benefits, or coverage of services (King,
C. 2016; Parish, S.L. et al., 2015; Douglas, M.D., et al, 2017; Chatterji, P., et al., 2015; Wang, L.
et al., 2013; Barry, C., 2019). The variability in coverage leads individuals to experience very
different health care outcomes; again, contributing to the overall national health disparities.
The ability to afford care, have access to care, and advocate for care are tied to ethnicity,
insurance, geography, and SES status. If the greatest number of people diagnosed are limited to
individuals with insurance/coverage or who can afford care and can navigate the system then the
diagnosed prevalence of autism will be skewed toward specific populations, socio-economic
statuses, and coverage levels. Such factors will cause misrepresentation of the true prevalence of
autism. To meet the health care service demands a true estimate of prevalence needs to be found.
As with cultural barriers families living at or below the FPL may be underrepresented in the
national prevalence due to the lack of access to providers; a lack of representation affects the
estimations of use and cost of limited and expensive autism services.
A reduction of prevalence of a disorder results in the reduction in the utilization of
services and costs. Predictive research models estimated a decrease in prevalence following the
changes to the DSM due to strict criteria of the DSM (Mazurek, M.O. et al, 2017; Yaylaci, F.,
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&Miral, S., 2017; Bennett, M., & Goodall). This was not found as the prevalence continues to
rise despite limitations set by insurance companies, racial disparities, and economic/financial
hardships. Previous inquiries have examined the relationship between the cost of health care and
a diagnosis of autism, the effects of autism mandates on access/utilization/cost, as well as the
evaluation of the relationship between insurance type (e.g., government, public, private) and
access to services. To date, a study examining the relationship of a diagnosis of autism and
specific insurance types on a national level when other factors are controlled, has not been
investigated.
Theoretical Framework
The purpose of this study is to examine other possible factors contributing to the increase
in the prevalence of autism while controlling predisposing factors which influence access to care
(e.g., race, SES, geographic area). To do this, the study follows the theoretical model of the
Anderson and Newman Framework of Health Services Utilization (1995). The Anderson model
provides a method to measure access to health care services as a function of three population
characteristics: Predisposing Factors, Enabling Factors, and Need Factors. Predisposing Factors
are preexisting conditions an individual already experiences before a diagnosis. These are
individual level factors which influence health care habits such as ethnicity, cultural
considerations, and personal values and beliefs toward health care providers in general. (Lix, L.
et al., 2005). Enabling Factors are those which influence the logistics of how a person receives
care such as the ability to navigate different health care systems, the ability to utilize regular
source of transportation to access services, how to find available health professionals/facilities
within their area and individual psychological factors such as motivation and drive to seek out

49

treatment (Lix, L. et al., 2005). Need Factors are elements which generate from problems that
require immediate health care attention such as SIBs. Need factors also consider patients’
perceptions of the quality of care provided as well as a patient’s evaluation of how the care was
provided (Lix, L. et al., 2005).
This research is intended to consider the effects of environment (e.g., region, county,
home) on population characteristics, how population characteristics (e.g., socio-economic, race,
geography) influence health behaviors, and finally how health behaviors and access to health
(e.g., seeking care, navigation of insurance and insurance coverage) influence health outcomes
(e.g., prevalence levels and autism diagnosis). The factors in Anderson’s model directly align
with the questions of the study regarding the effect of changes in the study populations of SES,
ethnicity, geography, and insurance type overtime as well as the question of a whether a
relationship exists between an autism diagnosis and specific type of insurance.
Summary
Access to health care services has long been difficult for children born with
developmental disabilities. Problems accessing care are furthered when a child with autism are of
minority status, lives in a non-metro geographic area or from a lower-socioeconomic income
bracket. The introduction of the autism mandates and expansion of Medicaid were meant to
increase access and they did, for some. For others not covered by the mandate legislation or
those who didn’t qualify for Medicaid it did not. As a result, many children with autism still have
a barrier to accessing diagnosing providers due to of a lack of insurance coverage.
The refinement of the autism criteria in the DSM-5 was meant to increase the accuracy of
an autism spectrum diagnosis while helping control the increased level of prevalence. Previous
research suggested the removal of the PDD sub-category diagnoses would result in a reduction of
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people identified with autism spectrum disorders, positing that the DSM-5 was not sensitive
enough to accurately capture the subtle differences between mild forms of autism. This change
would leave people with former diagnoses of PDD and AS without a diagnosis and therefore
potentially face a loss of access to services. Other research posited that a measurable reduction
of prevalence would not occur since the changes now included the SCD diagnosis and also
allowed the historical diagnoses of autism to continue under the new criteria.
Yet, even with the addition of the SCD diagnosis, evaluating the strict ASD diagnosis
criteria, considering issues of barriers to insurance coverage, factors associated with
socioeconomic status, potential effect of geographic region, and consideration of the disparities
between racial groups and possible under representation of minorities, the national prevalence
has continued to increase. In fact, with every refinement of the DSM criteria, the prevalence of
autism has continued to increase. Other factors, such as increased public awareness/acceptance
of autism, expanded insurance coverage and improved diagnoses and screening practices have
been considered as variables associated with the increase in prevalence; however, these three
factors cannot account for all increases in prevalence. Determining if other factors that might be
reflected in evaluating insurance type used by the family might contribute to the prevalence of
autism is important since the relationship between diagnoses codes and insurance coverage for
therapeutic services for other conditions has already been established. Diagnoses rates influence
the rates of utilization of services as well as the overall cost of care. In addition, prevalence of a
conditions such as autism influences policy and legislation at local, state, and federal levels since
decisions regarding insurance coverage, cost and access are often decided based on the reported
prevalence of a health condition (Monz, B.U., 2019; Thomas, K et al., 2012; Nuyen, C. T., 2016;
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Zeleke, N., et al., 2019; Karpur, A. et al., 2018). Understanding the factors which influence the
diagnosis of autism will provide decision makers with data that is valuable for making changes
to coverage, staffing, service provision, and reimbursement. These changes in turn enhance the
ability to access capable providers, which is key for accessing necessary therapies.
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CHAPTER III
METHODS
To answer the questions regarding the relationship between the types of insurance
coverage and a diagnosis of ASD, this study examines variables over two distinctive years.
To mark the years pre-mandate/pre-DSM revision the year 2010 was chosen and to mark the
post-mandate/post-DSM revision the year 2018 was chosen. The best way to retroactively
analyze the relationship between insurance and autism diagnoses is through the analysis of
secondary data. The data set chosen for this task is accessible through the web-based databank at
the University of Minnesota. The data was derived from the National Health Interview Survey
(NHIS) which is an annual survey used to analyze health trends and outcomes in the United
States. The focus on the specific relationship between the type of insurance and rates of autism
diagnosis while holding SES, race and region constant is to determine other possible factors
influencing the continued increase in the prevalence of autism over the years. Consent to use the
data from the survey was provided by the participants prior to participation in the surveys.
HSIRB approval was given by Western Michigan University’s IRB committee for exempt
studies examining secondary data.
Research Questions/ Hypotheses
This study was designed to answer two questions 1) “Is there a change in proportions of
insurance type or predisposing characteristics over time and is it significant?” and 2) “Are
specific insurance types such as Medicaid, Tricare, and Private, associated with the diagnosed
prevalence of autism following the changes to the DSM?”. The research literature has suggested
that individuals with Medicaid have an increase in coverage for a wider variety of services under
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the ACA. Previous research also suggests that the implementation of the autism insurance
mandates have been found to have increased access to health care services for some individuals
with private insurances (Foxhall, K., 2015; Barry, C., 2019; Stuart, E., McGinty, E., Kalb, L.,
Huskamp, H., Busch, S., Gibson, T., Barry, C., 2017; Berlin Baller, J., et al., 2016; Shea, L. L.,
et al., 2018).
National Health Interview Survey
Population and Sample
For this study, children from 0-18 years of age residing in the United States whose
parents completed the National Health of Interview Survey (NHIS) for the years 2010 and 2018,
and whose parents reported their child was given the diagnosis of autism are included in the
extracted data set. The NHIS is an annual face to face survey of households in the United States.
The NHIS dataset has a yearly sample size of n= 87,500. Using the exclusion criteria presented
above, the final sample size for this study was n =162, 807.
The NHIS relies on a stratification and clustering sampling strategies to survey
individuals residing in households and “non-institutionalized, multiple people living units” (e.g.,
apartments) (IPUMS, 2019). Geographic regions are divided into primary sampling units (PSU)
such as local counties. Cluster samples are nested with a PSU from which addresses within are
chosen to participate in the survey. Finally, the survey is distributed to the selected addresses in
the selected PSUs.
Instrumentation
The outcome and predictor variables chosen for this study are taken from an NHIS data
available through the University of Minnesota’s Institute for Social Research and Data
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Innovation. The Institute provides researchers access to an extensive bank of secondary data
from over 750 health and census data archives (Lynn, A.B. et al., 2019). The Integrated Public
Use Microdata Series (IPUMS) data bank at the University of Minnesota synchronizes and
records the variable codes from the survey (Lynn, A.B. et al., 2019). The survey variables are
assigned specific codes which are documented in a manner which allows researchers to make
comparisons across various years of NHI survey data. As described, the survey questions were
previously administered by NHIS volunteers in person. All the survey responses were recorded
in real time using close-ended, multiple choice answers. The responses were aggregated,
organized, and recoded by category and stored in the IPLUMS databank at the University of
Minnesota. To access the databank, a request was made to extract variables for the requested
years (e.g., 2010 and 2018). Once the data request was approved, a key was provided to access a
downloadable SPSS data file. All data analyzed was previously deidentified prior to extraction
and stored on a secure, finger-print protected laptop.
Operation of Variables
The variables of interest in this study are derived from questions on the National Health
Interview Survey (NHIS) for the years 2010 and 2018. The outcome variable of interest is a
diagnosis of an autism spectrum disorder. The survey question best representing this variable is:
“Have you ever been told your child has autism?” The principal predictor variable to be
examined in this study are type of insurance and preexisting characteristics. Questions from the
survey best representing the types of insurance coverage are: “Do you have any Medicaid/other
public assistance” (e.g., all public health plans), “Are you covered by military health insurance?”
(e.g., CHAMPUS, TRICARE, VA), “Do you have private insurance that you’ve purchase
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directly?” (e.g., purchased through health care exchange or other open market health insurance
exchanges), “Do you have private insurance paid in part or full by your employer?” (e.g., all
insurances which employer contributes to the premium costs). It is hypothesized there will be a
relationship between one or more of the insurance types and a diagnosis of autism given the
expansions in coverage over time. Additional predisposing variables of interest were selected
based on region of the U.S. (e.g., Northeast, North Central/Midwest, South, West), race/ethnicity
(e.g., White, Black, Native/Alaskan, Asian/Pacific Islander, Hispanic), socio-economic status
(e.g., at or above poverty level and below poverty level) and how recently an individual visited a
provider (e.g., within the last 12 month or more than 12 months).
The variable of timing of last provider visit was considered since diagnoses of autism are
contingent upon visiting a provider. Therefore, visiting a provider within the last 12 months
before completing the NHIS survey along with having a diagnosis of autism could be an
indication that in this dataset, the timing of provider visits may be correlated with a diagnosis of
autism, as well as with the response to the survey question which asked, “Have you been told
your child has autism”. This very general, self-reported item on the survey does not specify if the
person with autism has a medical diagnosis of autism or if it was diagnosis within the system, but
only that at some point the respondent has been told “your child has autism”, regardless of the
source. It is estimated that 75% of all the ASD cases in the U.S (McGrath, K. & Mann, M. 2020)
are first diagnosed in the educational setting. Since access to medical treatments are dependent
up on a medical diagnosis of autism and not special education eligibility, it is important in this
study to investigate whether a reported diagnosis of autism was related to a recent provider visit,
given that insurance coverage becomes an issue only if a medical provider is the source of the
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diagnosis. Evaluating the change in diagnosing practices for autism (e.g., DMS-5) and
insurance coverage over time is potentially influenced by how frequently an individual visited a
provider, since insurance only becomes important with a medical diagnosis of autism. This
variable is an attempt to validate a medical diagnosis of autism.
The years 2010 and 2018 were secondary predictor variables representing the period prior
to and following the autism insurance mandates (effective 2010-12) and the full implementation
of the DSM-5 (effective after 2013). The large interval provided time for the effect of
implementation to take effect. This also allowed for accounting for the impact of late
implementation of some states in adopting the mandates, and for allowed health care entities to
fully change to following the criteria of the DSM-5.
Analysis
For purposes of analysis, all the multiple-choice questions from the survey associated
with the dependent and independent variables were recoded from multiple categories into binary
categorical variables of “yes” or “no” To increase the chances of analyzing only “true” yes or
no responses, the “Not in Universe” (NIU), “Refused to Answer”, and “I Don’t Know” (see
Operational Definition of the Variables) removed from consideration.
Descriptive analysis and frequency counts were performed on all variables to determine
if patterns exist within and among the variables. A z-test of proportions (two tailed test, p =.05
alpha level) was performed following the descriptive analysis to answer the question if there
were changes in the proportions of the predictor variables between the years of 2010 and 2018.
To evaluate and answer the question regarding if a relationship between the type of insurance an
individual uses and a diagnosis of an Autism Spectrum Disorder exists a binomial logistic
regression was conducted.
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Other variables considered in the analysis were socio-economic status (e.g., above or
below FPL), geographic region (e.g., north, Midwest, south, west), ethnicity (e.g., White, Black,
Native, Asian), and how recently an individual had visited the doctor (e.g., with in 12 months or
more than 12 months). Additionally, interaction terms associated with visiting a provider and
geographic region and visiting a provider and type of insurance were considered to determine if
these variables influenced the likelihood of being diagnosed with autism above and beyond the
primary variable of interest (insurance type). The predictor variables were analyzed through a
simultaneous entry method SINCE there was no theoretical basis for one insurance type or
covariate having a presumed relationship more than any of the other variables. All statistical
analysis was completed using SPSS version 27.
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CHAPTER IV
RESULTS
Descriptive statistics were calculated for each variable to examine distribution
comparability across variables. Prior to the analysis all the survey variables were recoded into
dichotomous “yes” and “no” categories to ensure only “true” “yes” and “no” answers were
included in the analysis. The dependent variable related to the presence or absence of Autism
(e.g., ASD Yes or ASD No) and independent variables related to the years pre and post
DSM/Insurance mandates (e.g., 2010 and 2018), type of insurance (e.g., Medicaid, Military,
Private Self-Pay and Private Employer Pay), ethnicity, SES, geographic region and last visit with
a providers (e.g., Within the last 12 months or more than 12 months since last visit) were
included in the z-test and regression model to answer the questions of a change in proportion
over time and if a relation between a diagnosis of autism and insurance type exists.
The demographic characteristics of the survey participants and crosstabulation proportion
percentages are expressed below in Table 1.
Table 1: Demographic information for variables related to predisposing conditions of recipients of autism diagnoses
using the DSM IV and DSM -5 from the NHIS survey (N= 162, 807)

Demographic Variables
Frequency for 2010
Ethnicity:
White
66741
Black
14854
Native
994
Asian
6721
Region
North
14095
South
32804
Midwest
18238
West
24839
Income
At or above poverty level
64190
Below poverty level
14830

Frequency for 2018
57267
8953
1171
4648
12089
26431
16092
18219
60405
7515

59

The z-test was performed to determine if the proportion changed between the year prior
to the DSM changes and the implementation of the insurance mandates, the results of which are
contained in Tables 2 and 3.
Table 2: Insurance coverage changes over time in those who received autism diagnoses under the DSM IV and DSM
-5 from NHIS data (N= 162, 807)
Significant Variables: Type of Insurance z score
p value
Proportion % for
Proportion % for
2010 (DSM IV)
2018 (DSM 5)

Medicaid (n=161,312)
Military Based (n= 161,318)
Employer Provided (n=47804)

6.65
-21.94
29.02

p<.00001
p<.00001
p<.00001

19%
3%
77%

18%
5%
69%

*private insurance did not have a value for 2018
therefore a proportion was not found

Table 3: Change in theoretically influential variables over time for those who received a diagnosis of autism under
the DSM IV and 5 from NHIS data (N = 162, 807)
Significant Variables: Demographic z score
p value
Proportion % for
Proportion % for
2010 (DSM IV)
2018 (DSM 5)

Ethnicity:
White (n =124,008)
Black (n =23,807)
Native (n = 2,165)
Asian (n=11,369)

-23.45
22.87
6.49
42.01

p<.00001
p<.00001
p<.00001
p<.00001

74%
16%
11%
7%

79%
12%
1%
6%

-5.55
158.2
-9.86
9.13
37.69

p<.00001
p<.00001
p<.00001
p<.00001
p<.00001

15%
36%
20%
27%

16%
36%
22%
25%

18%

11%

-14.4

p<.00001

78%

86%

Region
North (n=26,184)
South (n =59,235)
Midwest (n=34,330)
West (n=43,058)
Income
(n= 146,840)
Provider Visit
(n = 19, 408)

All variables included in the analysis that were found to have a significant change in
proportion between the years pre and post changes to the DSM and implementation of the
insurance mandates were included in the logistic regression. While the difference in proportion
over time was found to be significant, the percent of change was minimal and determined to be
not noteworthy. The geographic variable and last visit with a provider variable were included in
the regression model even though the change in proportion between the years was minimal
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(Table 3) since some research suggests that geographic region of residence and timing of visits
with providers could be influencing factors in the ability to access autism health care services.
The results of the regression model are shown in Table 4. The logistic regression model
was statistically significant, X2 = 62.335, p <.000. The model explained 5.4% (Nagelkerke R2) of
the variance in autism and correctly classified 98.7% of the diagnosed cases of autism (e.g.,
autism yes). Of the predictor variables included in the model, the variables which were
statistically significant were the year (OR 1.12, p =.000), living in the south (OR .054, p = .013),
living in the west (OR 0.116 , p = .021), and Medicaid insurance (OR 4.99, p = ≤.001) as well as
the interaction variables of visiting a provider within the last 12 months *residing in the south
(OR 12.79, p = .036) and visiting a provider within the last 12 months * residing in the west (OR
8.42, p = .029) (see Table 4)
Table 4: Logistic regression results of variables associated with diagnosis of autism under the DSM-IV and DSM-5
from NHIS for the years 2010 and 2018 (N= 162,807)
Predictor Variables Included in the Regression Model
Wald
OR
%95 CI
sig. p <.05
+ = variables found to significantly related to an ASD Diagnosis

Insurance Type

Year+
Region

Medicaid+ 24.18
Military Based .073
Employer Based 1.71
2.93
North Region (referent)
South Region+
West Region+
Midwest Region

9.26
4.41
5.30
1.178

4.99
.943
.458
1.12

2.63-9.48
.613-1.44
.143-1.47
.983-1.28

<.001
.0788
.190
.087

.054
.116
.457

.005-.547
.019-.725
.111-1.88

.026
.013
.021
.278

Income
SES .000

.000

.000

.997

Ethnicity
White (referent)
Black
Native
Asian
Provider Visit
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18.59
1.001
.002
1.5
3.44

.710
1.04
.594
.218

.363-1.38
.140-7.88
.258-1.36
.044-1.08

.501
.317
.963
.220
.063

Table 4 – Continued
Interaction Terms
Provider Visit *North (referent)
Provider Visit *South+
Provider Visit *West+
Provider Visit *Midwest
Provider Visit *Medicaid
Provider Visit *Military
Provider Visit *Employer
Provider Visit *SES
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8.99
4.41
4.78
.141
.469
.000
1.74
.000

12.79
1.18-137.78
8.42
1.24-56.66
1.34
.288-6.25
.539
.092 – 3.1
.218
.000
2.34
.662- 8.33
39220182.4 .000

.029
.036
.029
.707
.494
1.000
.186
.997

CHAPTER V
DISCUSSION
Prior to the release of the DSM-5, previous research predicted an average reduction of
30% in the number of individuals receiving an ASD diagnosis since the DSM-5 has been found
to under identify individuals with mild severities of Autism (e.g., Asperger’s or PDD-NOS)
(Peters, W., & Matson, J., 2019; McPartland, J. 2012; Worley and Matson 2012; Cooper, R.,
2014). A previous study examining the proportion of individuals concluded that the total
proportion of individuals not receiving an Autism diagnosis did not significantly change at the
.05 level between the DSM-IV and the DSM-5 even though the overall proportion increased by
1.3 percent (Thompson, J. 2018,). Since the results of this study did not support the previous
claims of a 30% reduction in prevalence on a national level other questions arose concerning the
influence insurance coverage and access to providers were raised. As a result, this research was
designed to investigate other associations related to diagnosis of autism, and to answer the
questions, “Is there a significant change in proportions of insurance type or predisposing
characteristics?” and “Are specific insurance types such as Medicaid, Tricare, and Private,
associated with the diagnosed prevalence of autism following the changes to the DSM?”. The
change in the proportions of all the predictor variables were statistically significant over 8 years.
While the change in the proportions were found to be significant, the percent of change over time
was minimal (e.g., Medicaid change was 1.2%, Employer provided insurance change was 11%,
etc.). This may be due to continuously changing federal guidelines for what is considered “living
below the federal poverty level”, since the FPL standards for Medicaid eligibility fluctuate as the
economy and/or political administrations change. These types of ongoing and unpredictable
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changes can affect the qualifying threshold levels of socioeconomic status for Medicaid
eligibility. In addition, individual employers can choose whether to provide their employees with
insurance coverage and to set the terms of the coverage, potentially resulting in employed
individuals not having employer-based insurance for certain conditions or at all, and thereby
influencing the proportions with reported insurance coverage.
Logistic regression analysis determined that there was an association between the
diagnosis of autism and Medicaid insurance. This analysis also considered other variables such
as geographic region, ethnicity, SES and reported last visit with a provider as potentially
influencing an autism diagnosis. Other main effects variables were not significant, suggesting the
influence geography, SES and ethnicity is minimal. Additionally, the interaction between
reporting the time frame for visiting a provider (within the last 12 months) and region of the
country were examined since previous literature has suggested regional variations may be
important. In fact, certain regions of the country, such as southern states, do have less available
providers than others (e.g., due to a high number of rural and LSES areas). The results of the
logistic regression analysis found a significant relationship between Medicaid, geography and the
interaction term of geography and visiting a provider within the last 12 months (for two
geographic regions). The relationship between Medicaid and a diagnosis of autism was not
surprising since previous studies suggested Medicaid is reported to cover a wider variety of
autism services such as compared to private insurances. While private insurances have been
found to reimburse providers for autism services at a higher rate compared to Medicaid the
differences, lack of coverage and/or limitations on reimbursement for services between the
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various private insurance types (e.g., BCBS, Aetna, etc.) can result in a lack of access to
diagnosing providers for some individuals.
A possible reason for the relationship between geographic region, the interaction between
region and last provider visits and a diagnosis of autism could be attributed to a few things. For
example, from a geographic standpoint, some regions have a higher concentration of large urban
areas. It is also possible that larger urban areas provide not only an increase in access
opportunities for clinical and diagnosing services (since there are likely an increased number of
providers living in urban areas), but could also have larger, more well-established school-based
services. It is important to note that while significant, and with large odds ratios reported for the
two significant interactions (OR provider visit * South = 12.79, OR provider visit * West =
8.42), the confidence intervals for these interaction terms were very wide (e.g., visit with a
provider * southern region CI = 1.2 – 137.8). The wide range of confidence intervals may be due
to the wide range of services both clinically and educationally in the metro versus non-metro
geography of the south and west, which often has a larger concentration of people in one
metropolitan area (such as Atlanta, GA compared to areas such as rural Mississippi). In short, the
predictor variables of geographic region and timing of last visit may be reflective of wide
variations in the regional capacities.
Finally, from an insurance perspective, since individual state insurance regulations often
affect autism diagnosis, variations among and between states in regions makes it impossible to
view geographic regions as monoliths. Additionally, states did not adopt the federal autism
mandates within the same time frame as some states were quick to adopt the mandates and other
didn’t full adopt the mandates until several years after they were required. Despite the significant
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relationship, absent a national insurance policy, there is no way to impose insurance standards
across state lines, as such the relationship between geographic region is difficult to interpret as
federal guidelines for insurance coverage are not regionally adapted or applied in the same
manner. What can be concluded however is that the regions are different regarding the regional
influence on provider visit since the influence of North or Midwest was not significant. Further
research considering state by state variations in access to providers, insurance coverage and
diagnosis rates should be conducted to determine if these findings are real or artifacts of
variations within a geographic region.
Since only reported Medicaid coverage was significantly related to a diagnosis of autism,
the results from this study prompt further questions about the influence of insurance coverage
and reimbursement for services and access to care. If Medicaid is the only insurance which is
covering services at a higher rate this could influence the willingness of providers to accept
patients with other types of insurance. This could lead to a large portion of the population with
insurance coverage other than Medicaid with limited access to a diagnosing provider, thereby
influencing the overall reported diagnosed of autism.
The overarching results of this study suggest that the type of insurance does factor into
how and when someone will see a diagnosing provider. Since age at which someone is
diagnosed impacts outcomes in therapy, and a later diagnosis of autism often results in increased
symptoms it is clinically important that individuals are seen as early as possible (Cheak-Zamora,
N.C. et al., 2017; Lello, A., et al., 2016; Travers, J. & Krezmien, M., 2018; Adelman, C.R. &
Kubiszynm T., 2017; Daniels, A.M. and Mandell, D.S., 2014). Results of analysis of types of
insurance coverage suggest that individuals with private insurances or without insurance
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coverage are at a significant disadvantage when attempting to access a diagnosing provider in
any region of the United States.
The strengths of this study are in the large sample size of national data and the
conservative analysis approach. The national level data allowed for a large sample to be
analyzed. In removing all the “extra” survey response choices (e.g., NIU, I don’t know and No
Response) only the “true” yes and no responses for a diagnosis of autism and type of insurance
held was included in the analysis allowing for increased accuracy in responses analysis of “yes”
and “no” responses.
One of the main limitations of the study was the decision to remove all the “other”
responses when recoding variables for analysis. In reducing the data set a large portion of the
sample was excluded which may have inflated the “yes” percentages as “unknown” responses
could have been either true “yes” or “no” responses. A second limitation is, to evaluate change
over time, the best method is survey data. When implementing nation-wide surveys there can be
complications with administration (e.g., user error), misinterpretation of the questions (e.g., by
the respondent) or misinterpretation of the responses (e.g., administrator). In addition, as the
data was de-identified and recoded prior to its’ addition to the database it is unknown if
the same participants completed the survey in both years, limiting the data on the number
of individuals who maintained, lost, or received Autism diagnoses. Finally, the survey is
completed by any adult dwelling at the residence who chooses to participate in the survey. This
can lead to family members completing the survey without accurate knowledge of the health
conditions and status of other individuals in their household.
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The implications for this study are wide as access to care is dependent upon insurance
coverage and/or the ability to pay for health care services. If diagnoses are tied to specific
insurances, this points a larger problem with inequalities in health care coverage in as outlined in
the introduction of this paper since individuals who are more likely to have Medicaid coverage
are White individuals living at or slightly above poverty level. This excludes all other
populations continuing to increase the disparities in health care. The results of this study add to
the body of evidence of health care disparities and equities in coverage. This information will be
helpful in advocating for the increased access to care and expanded insurance coverage for
people on the autism spectrum. Advocating for legislation reform at the state level to add or
change licensing legislation to allow practitioners to be licensed with the state to provide autism
services will be a start. In addition, state governments can be encouraged to write consistent laws
for private insurances with the goal of reducing coverage variations among private insurance
providers. State governments can also rewrite laws to codify autism services as a “standard” for
care as with other disorders, such as ADHD, thereby requiring employers to include autism
coverage in their benefits package. On a larger scale, the implementation of a national health
insurance one-payer system could significantly reduce the disparities in access for people with
autism spectrum disorders as everyone, regardless of region of the country, income level or
employment status would have the same access to coverage and health care.
Future research should examine difference between specific geographic areas such as
metro versus non-metro, access to autism specific providers such as comprehensive diagnoses
teams and autism diagnosis as specific way of measuring the differences in geographic region
and visits with providers.
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Appendix A:
Definition of Key Terms
The following terms are used specifically in Speech-Language Pathology and/or the health care
community as they relate to the diagnosis and treatment of autism.
Term 1: ASD: Autism Spectrum Disorder: “any of a group of developmental disorders
marked by impairments in the ability to communicate and interact socially
and by the presence of repetitive behaviors or restricted interests Autism
spectrum disorder.”
The Merriam-Webster.com Dictionary. Retrieved December 28, 2019, from
https://www.merriam-webster.com/dictionary/autism%20spectrum%20disorder
Term 2: ABA: Applied Behavioral Analysis: “psychological therapy that uses techniques
developed from the objective analysis of observable behavior to make
changes to socially significant behaviors that are abnormal or harmful”
The Merriam-Webster.com Medical Dictionary. Retrieved December 28, 2019, from
https://www.merriam-webster.com/medical/applied%20behavior%20analysis.
Term 3: EIBI: Early Intensive Behavioral Intervention: “Consists of 20-40 hours per
week of individualized instruction for children with autism beginning at
the age of 4 years or younger and continues for 2-3 years.:
Association for Science in Autism Treatment. Retrieved December 28, 2019, from
https://asatonline.org/for-parents/learn-more-about-specific-treatments/early-intensivebehavioral-interventiontreatment-2/.
Term 5: SLP/ST: Speech-Language Pathologist/Speech Therapist/Therapy: A
professional working in the medical or education field who “prevents,
assesses, diagnosis and treats speech, language, social communication,
cognitive-communication, and swallowing disorders in children and
adults”.
American Speech-Language and Hearing Association. Retrieved December 28, 2019, from
https://www.asha.org/Students/Speech-Language-Pathologists/
Term 6: Autism Mandates: Legislature passed in the late 2000’s requiring private,
commercial insurance plans to cover the treatment for autism. The mandates do
not include self-funded plans.
American Speech-Language and Hearing Association. Retrieved January 2, 2020, from
https://leader.pubs.asha.org/doi/10.1044/leader.BML.24042019.30
Term 7: Self-funded Health Insurance: A type of plan in which an employer takes on
most or all the costs of the benefit claims and is the one to pay the claims.
Aetna. Retrieved January 2, 2020, from https://www.aetna.com/employers-organizations/selfinsurance-plans.html
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Term 8: Public health Insurance: A program run by federal, state, or local government.
The main public health insurance for children with disabilities is Medicaid.
National Cancer Institute. Retrieved January 2, 2020, from
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/public-health-insurance
Term 9: Private Health Insurance: Any health insurance plan that is not run by the federal
or state government. Private Insurance is provided through employers,
state/federal marketplaces, or private marketplaces.
Term 10: DSM-IV/5: The Diagnostic and Statistical Manual is the rule book for making
psychiatric diagnosis used by most mental health professionals.
Periodically, the American Psychiatric Association updates the
manual to reflect changes in research.
American Psychiatric Association. Retrieved on January 2, 2020, from
https://www.psychiatry.org/psychiatrists/practice/dsm/feedback-and-questions/frequently-askedquestions
Term 11: AD: Autistic Disorder: stand-alone diagnosis for individuals who demonstrated
difficulty with social language, behavior, and social skills in the DSM-IV,
now included in the DSM-5 Autism Spectrum.
University Of Michigan Medicine. Retrieved on January 2, 2020, from
http://www.med.umich.edu/yourchild/topics/autism.htm
Term 12: PDD/PDD-NOS: Pervasive Developmental Disorders (Not Otherwise
Specified): stand-alone diagnosis for individuals who demonstrated
difficulty with social language, behavior, and social skills but not to the same
extent as an individual with autism and did not meet criterion for an autism
spectrum disorder DSM-IV, now included in the DSM-5 Autism Spectrum.
University Of Michigan Medicine. Retrieved on January 2, 2020, from
http://www.med.umich.edu/yourchild/topics/autism.htm
Term 13: Asperger’s Disorder: stand-alone diagnosis for individuals with normal
intelligence and language development but also some autistic-like traits such as
rigidity and restricted interests but do not meet criterion for an autism spectrum
disorder, now included in the DSM-5 Autism Spectrum Disorder.
University Of Michigan Medicine. Retrieved on January 2, 2020, from
http://www.med.umich.edu/yourchild/topics/asperger.htm
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Appendix B:
Anderson’s Model for Health Care Utilization of Services
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